{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:18:51Z","timestamp":1789845531686,"version":"4.0.1"},"reference-count":376,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"DOI":"10.1186\/s12959-025-00797-7","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T08:44:59Z","timestamp":1764319499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Molecular diagnosis of inherited platelet disorders: a tale of two realities \u2013 advanced vs. resource-limited setting"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9840-1413","authenticated-orcid":false,"given":"Seyed Mehrab","family":"Safdari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4520-0899","authenticated-orcid":false,"given":"Sina","family":"Jozdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8562-8575","authenticated-orcid":false,"given":"Mahsa","family":"Mottaghizadeh-Jazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6394-1156","authenticated-orcid":false,"given":"Maryam","family":"Shayanmanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7686-0822","authenticated-orcid":false,"given":"Alireza","family":"Khanahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6861-3095","authenticated-orcid":false,"given":"Mehdi","family":"Bakhtiyaridovvombaygi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0456-7148","authenticated-orcid":false,"given":"Azadeh","family":"Rezazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9875-8391","authenticated-orcid":false,"given":"Shadi","family":"Tabibian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"issue":"7","key":"797_CR1","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1055\/s-0039-1687889","volume":"45","author":"JM Bastida","year":"2019","unstructured":"Bastida JM, Benito R, Lozano ML, Mar\u00edn-Quilez A, Janusz K, Mart\u00edn-Izquierdo M, et al. Molecular diagnosis of inherited coagulation and bleeding disorders. Semin Thromb Hemost. 2019;45(7):695\u2013707.","journal-title":"Semin Thromb Hemost"},{"issue":"11","key":"797_CR2","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1111\/jth.12672","volume":"12","author":"VS Blanchette","year":"2014","unstructured":"Blanchette VS, Key NS, Ljung LR, Manco-Johnson MJ, van den Berg HM, Srivastava A. Definitions in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost. 2014;12(11):1935\u20139.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"797_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.medcli.2016.09.014","volume":"148","author":"JM Bastida Bermejo","year":"2017","unstructured":"Bastida Bermejo JM, Hern\u00e1ndez-Rivas JM, Gonz\u00e1lez-Porras JR. Novel approaches for diagnosing inherited platelet disorders. Med Clin (Barc). 2017;148(2):71\u20137.","journal-title":"Med Clin (Barc)"},{"issue":"3","key":"797_CR4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1055\/s-0035-1570078","volume":"42","author":"P Gresele","year":"2016","unstructured":"Gresele P, Bury L, Falcinelli E. Inherited platelet function disorders: algorithms for phenotypic and genetic investigation. Semin Thromb Hemost. 2016;42(3):292\u2013305.","journal-title":"Semin Thromb Hemost"},{"key":"797_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094521","author":"V Palma-Barqueros","year":"2021","unstructured":"Palma-Barqueros V, Revilla N, S\u00e1nchez A, Zamora C\u00e1novas A, Rodriguez-Al\u00e9n A, Mar\u00edn-Qu\u00edlez A, et al. Inherited platelet disorders: an updated overview. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22094521.","journal-title":"Int J Mol Sci"},{"key":"797_CR6","doi-asserted-by":"crossref","unstructured":"Noris P, Pecci A. Hereditary thrombocytopenias: a growing list of disorders., Hematology 2014. The American Society of Hematology Education Program Book. 2017;2017(1):385\u2009\u2013\u200999.","DOI":"10.1182\/asheducation-2017.1.385"},{"key":"797_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10030533","author":"L Bury","year":"2021","unstructured":"Bury L, Falcinelli E, Gresele P. Learning the ropes of platelet count regulation: inherited thrombocytopenias. J Clin Med. 2021. https:\/\/doi.org\/10.3390\/jcm10030533.","journal-title":"J Clin Med"},{"issue":"4","key":"797_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.tmrv.2020.09.006","volume":"34","author":"A Al-Huniti","year":"2020","unstructured":"Al-Huniti A, Kahr WH. Inherited platelet disorders: diagnosis and management. Transfus Med Rev. 2020;34(4):277\u201385.","journal-title":"Transfus Med Rev"},{"issue":"2","key":"797_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3324\/haematol.2020.248153","volume":"106","author":"P Nurden","year":"2021","unstructured":"Nurden P, Stritt S, Favier R, Nurden AT. Inherited platelet diseases with normal platelet count: phenotypes, genotypes and diagnostic strategy. Haematologica. 2021;106(2):337\u201350.","journal-title":"Haematologica"},{"issue":"5","key":"797_CR10","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/j.1365-2141.2006.06343.x","volume":"135","author":"PH Bolton-Maggs","year":"2006","unstructured":"Bolton-Maggs PH, Chalmers EA, Collins PW, Harrison P, Kitchen S, Liesner RJ, et al. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol. 2006;135(5):603\u201333.","journal-title":"Br J Haematol"},{"issue":"3","key":"797_CR11","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/jth.14683","volume":"18","author":"P Gresele","year":"2020","unstructured":"Gresele P, Orsini S, Noris P, Falcinelli E, Alessi MC, Bury L, et al. Validation of the ISTH\/SSC bleeding assessment tool for inherited platelet disorders: a communication from the platelet physiology SSC. J Thromb Haemost. 2020;18(3):732\u20139.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"797_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/09537104.2016.1195492","volume":"28","author":"A Maclachlan","year":"2017","unstructured":"Maclachlan A, Watson SP, Morgan NV. Inherited platelet disorders: insight from platelet genomics using next-generation sequencing. Platelets. 2017;28(1):14\u20139.","journal-title":"Platelets"},{"key":"797_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/biom15060846","author":"A S\u00e1nchez-Fuentes","year":"2025","unstructured":"S\u00e1nchez-Fuentes A, P\u00e9rez-Botero J, Bastida JM, Rivera J. Diagnosis of inherited platelet disorders: clinical evaluation and functional and molecular assays. Biomolecules. 2025. https:\/\/doi.org\/10.3390\/biom15060846.","journal-title":"Biomolecules"},{"key":"797_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/978-1-4939-7196-1_24","volume":"1646","author":"AM Hvas","year":"2017","unstructured":"Hvas AM, Grove EL. Platelet function tests: preanalytical Variables, clinical Utility, Advantages, and disadvantages. Methods Mol Biol. 2017;1646:305\u201320.","journal-title":"Methods Mol Biol"},{"issue":"2","key":"797_CR15","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/jth.12792","volume":"13","author":"P Gresele","year":"2015","unstructured":"Gresele P, Harrison P, Gachet C, Hayward C, Kenny D, Mezzano D, et al. Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH. J Thromb Haemost. 2015;13(2):314\u201322.","journal-title":"J Thromb Haemost"},{"issue":"23","key":"797_CR16","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1182\/blood-2016-03-378588","volume":"127","author":"C Lentaigne","year":"2016","unstructured":"Lentaigne C, Freson K, Laffan MA, Turro E, Ouwehand WH. Inherited platelet disorders: toward DNA-based diagnosis. Blood. 2016;127(23):2814\u201323.","journal-title":"Blood"},{"issue":"8","key":"797_CR17","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1111\/jth.14945","volume":"18","author":"F Ver Donck","year":"2020","unstructured":"Ver Donck F, Downes K, Freson K. Strengths and limitations of high-throughput sequencing for the diagnosis of inherited bleeding and platelet disorders. J Thromb Haemost. 2020;18(8):1839\u201345.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"797_CR18","doi-asserted-by":"publisher","first-page":"e445","DOI":"10.1055\/s-0038-1676813","volume":"2","author":"O Andres","year":"2018","unstructured":"Andres O, K\u00f6nig EM, Althaus K, Bakchoul T, Bugert P, Eber S, et al. Use of targeted High-Throughput sequencing for genetic classification of patients with bleeding diathesis and suspected platelet disorder. TH Open. 2018;2(4):e445\u201354.","journal-title":"TH Open"},{"key":"797_CR19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/hae.12964","volume":"22","author":"SK Westbury","year":"2016","unstructured":"Westbury SK, Mumford AD. Genomics of platelet disorders. Haemophilia. 2016;22:20\u20134.","journal-title":"Haemophilia"},{"issue":"1","key":"797_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-025-00283-6","volume":"6","author":"Y Cai","year":"2025","unstructured":"Cai Y, Lin W, Deng J, Cheng Z, Tao Y, Lu H, et al. Application of multigene panel testing for bleeding, thrombotic, and platelet disorders in patients and the general population in China. Mol Biomed. 2025;6(1):39.","journal-title":"Mol Biomed"},{"issue":"23","key":"797_CR21","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1182\/blood.2018891192","volume":"134","author":"K Downes","year":"2019","unstructured":"Downes K, Megy K, Duarte D, Vries M, Gebhart J, Hofer S, et al. Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders. Blood. 2019;134(23):2082\u201391.","journal-title":"Blood"},{"issue":"10","key":"797_CR22","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3324\/haematol.2016.146316","volume":"101","author":"B Johnson","year":"2016","unstructured":"Johnson B, Lowe GC, Futterer J, Lordkipanidz\u00e9 M, MacDonald D, Simpson MA, et al. Whole exome sequencing identifies genetic variants in inherited thrombocytopenia with secondary qualitative function defects. Haematologica. 2016;101(10):1170\u20139.","journal-title":"Haematologica"},{"issue":"4","key":"797_CR23","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.jtha.2022.12.007","volume":"21","author":"C Van Laer","year":"2023","unstructured":"Van Laer C, Jacquemin M, Baert S, Labarque V, Thys C, Vanassche T, et al. Clinical application of multigene panel testing for bleeding, thrombotic, and platelet disorders: a 3-year Belgian experience. J Thromb Haemost. 2023;21(4):887\u201395.","journal-title":"J Thromb Haemost"},{"key":"797_CR24","unstructured":"NIHR BioResource, on behalf of the 100,000 Genomes Project, Writing Group, NIHR BioResource Principal Investigators, Ethics, Governance, Recruitment Coordination and Clinical Bioinformatics, Sample and Data processing: Congenica, EMBL-European Bioinformatics Institute, GENALICE, High Performance Computing Facility, University of Cambridge, Illumina, University of Cambridge, Software Development: High Performance Computing Facility, University of Cambridge. Whole-genome sequencing of rare disease patients in a national healthcare system. BioRxiv. 2019:507244."},{"issue":"7","key":"797_CR25","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1055\/s-0039-1687888","volume":"45","author":"AD Mumford","year":"2019","unstructured":"Mumford AD, Westbury SK. Genetic techniques used in the diagnosis of inherited platelet disorders. Semin Thromb Hemost. 2019;45(7):685\u201394.","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"797_CR26","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/humu.20164","volume":"25","author":"H Ren","year":"2005","unstructured":"Ren H, Francis W, Boys A, Chueh AC, Wong N, La P, et al. BAC\u2010based PCR fragment microarray: high\u2010resolution detection of chromosomal deletion and duplication breakpoints. Hum Mutat. 2005;25(5):476\u201382.","journal-title":"Hum Mutat"},{"issue":"2","key":"797_CR27","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.tjog.2020.01.024","volume":"59","author":"AM Travessa","year":"2020","unstructured":"Travessa AM, Dias P, Santos A, Cust\u00f3dio S, Sousa A, Sousa AB. Upper limb phocomelia: a prenatal case of thrombocytopenia-absent radius (TAR) syndrome illustrating the importance of chromosomal microarray in limb reduction defects. Taiwan J Obstet Gynecol. 2020;59(2):318\u201322.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"3","key":"797_CR28","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/bmt.2012.162","volume":"48","author":"M Stern","year":"2013","unstructured":"Stern M, Passweg JR, Meyer-Monard S, Esser R, Tonn T, Soerensen J, et al. Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers. Bone Marrow Transplant. 2013;48(3):433\u20138.","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"797_CR29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/pbc.22927","volume":"57","author":"AE Geddis","year":"2011","unstructured":"Geddis AE. Congenital amegakaryocytic thrombocytopenia. Pediatr Blood Cancer. 2011;57(2):199\u2013203.","journal-title":"Pediatr Blood Cancer"},{"key":"797_CR30","unstructured":"Petit F, Boussion S. Thrombocytopenia Absent Radius Syndrome. 2009 Dec 8 [updated 2023 Nov 2]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132025."},{"issue":"2","key":"797_CR31","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/bjh.15531","volume":"183","author":"M Faleschini","year":"2018","unstructured":"Faleschini M, Melazzini F, Marconi C, Giangregorio T, Pippucci T, Cigalini E, et al. ACTN1 mutations lead to a benign form of platelet macrocytosis not always associated with thrombocytopenia. Br J Haematol. 2018;183(2):276\u201388.","journal-title":"Br J Haematol"},{"key":"797_CR32","doi-asserted-by":"publisher","first-page":"783455","DOI":"10.3389\/fgene.2021.783455","volume":"12","author":"F Che","year":"2021","unstructured":"Che F, Zhao J, Zhao Y, Wang Z, Zhang L, Yang Y. A novel heterozygous pathogenic variation in CYCS gene cause autosomal dominant Non-Syndromic thrombocytopenia 4 in a large Chinese family. Front Genet. 2021;12:783455.","journal-title":"Front Genet"},{"key":"797_CR33","doi-asserted-by":"publisher","first-page":"5409","DOI":"10.1182\/blood-2023-186060","volume":"142","author":"K Giavi","year":"2023","unstructured":"Giavi K, Glentis S, Bouchla A, Apostolidou A, Marinakis NM, Kattamis A, et al. A novel variant of the CYCS gene alters apoptosis of megakaryocytes in a family with thrombocytopenia. Blood. 2023;142:5409.","journal-title":"Blood"},{"issue":"5","key":"797_CR34","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1080\/09537104.2018.1543866","volume":"30","author":"EC Ledgerwood","year":"2019","unstructured":"Ledgerwood EC, Dunstan-Harrison C, Ong L, Morison IM. CYCS gene variants associated with thrombocytopenia. Platelets. 2019;30(5):672\u20134.","journal-title":"Platelets"},{"issue":"6","key":"797_CR35","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1111\/bjh.19694","volume":"205","author":"J \u0160tika","year":"2024","unstructured":"\u0160tika J, Pe\u0161ov\u00e1 M, Kozub\u00edk KS, Skaln\u00edkov\u00e1 M, Dost\u00e1lov\u00e1 L, Loja T, et al. A novel thrombocytopenia-4-causing CYCS gene variant decreases caspase activity: three-generation study. Br J Haematol. 2024;205(6):2450\u20138.","journal-title":"Br J Haematol"},{"key":"797_CR36","unstructured":"Board PDQCGE. RUNX1-Familial Platelet Disorder (PDQ\u00ae): Health Professional Version. In: PDQ Cancer Information Summaries. Bethesda (MD): National Cancer Institute (US); 2002."},{"issue":"4","key":"797_CR37","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3324\/haematol.2018.214239","volume":"105","author":"JP Botero","year":"2020","unstructured":"Botero JP, Lee K, Branchford BR, Bray PF, Freson K, Lambert MP, et al. Glanzmann thrombasthenia: genetic basis and clinical correlates. Haematologica. 2020;105(4):888\u201394.","journal-title":"Haematologica"},{"issue":"8","key":"797_CR38","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1111\/jth.14827","volume":"18","author":"M Othman","year":"2020","unstructured":"Othman M, Gresele P. Guidance on the diagnosis and management of platelet-type von Willebrand disease: a communication from the platelet physiology subcommittee of the ISTH. J Thromb Haemost. 2020;18(8):1855\u20138.","journal-title":"J Thromb Haemost"},{"key":"797_CR39","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-243518","author":"M Monteiro","year":"2021","unstructured":"Monteiro M, Almeida L, Morais M, Dias L. Bernard soulier syndrome: a rare, frequently misdiagnosed and poorly managed bleeding disorder. BMJ Case Rep. 2021. https:\/\/doi.org\/10.1136\/bcr-2021-243518.","journal-title":"BMJ Case Rep"},{"key":"797_CR40","doi-asserted-by":"crossref","unstructured":"Ullah MI. Clinical and Mutation Spectrum of Autosomal Recessive Non-Syndromic Oculocutaneous Albinism (nsOCA) in Pakistan: A Review. Genes (Basel). 2022;13(6):1072.","DOI":"10.3390\/genes13061072"},{"key":"797_CR41","unstructured":"Toro C, Morimoto M, Malicdan MC, Adams DR, Introne WJ. Chediak-Higashi Syndrome. 2009 Mar 3 [updated 2023 Dec 21]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132025."},{"issue":"4","key":"797_CR42","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.anpede.2022.04.012","volume":"97","author":"A Regueiro Garc\u00eda","year":"2022","unstructured":"Regueiro Garc\u00eda A, Fari\u00f1a Nogueira S, Rujido Freire S, G\u00f3mez Silva G, Fern\u00e1ndez Sanmart\u00edn M. Gray platelet syndrome, more than just a bleeding disorder. Anales de Pediatr\u00eda (English Edition). 2022;97(4):288\u20139.","journal-title":"Anales de Pediatr\u00eda (English Edition)"},{"issue":"12","key":"797_CR43","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1007\/s00439-012-1215-x","volume":"131","author":"CL Balduini","year":"2012","unstructured":"Balduini CL, Savoia A. Genetics of familial forms of thrombocytopenia. Hum Genet. 2012;131(12):1821\u201332.","journal-title":"Hum Genet"},{"issue":"6","key":"797_CR44","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1055\/s-0031-1291382","volume":"37","author":"J Blavignac","year":"2011","unstructured":"Blavignac J, Bunimov N, Rivard GE, Hayward CP. Quebec platelet disorder: update on pathogenesis, diagnosis, and treatment. Semin Thromb Hemost. 2011;37(6):713\u201320.","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"797_CR45","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1111\/j.1939-1676.2012.01012.x","volume":"26","author":"KE Jandrey","year":"2012","unstructured":"Jandrey KE, Norris JW, Tucker M, Brooks MB. Clinical characterization of canine platelet procoagulant deficiency (Scott syndrome). J Vet Intern Med. 2012;26(6):1402\u20137.","journal-title":"J Vet Intern Med"},{"key":"797_CR46","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2147\/TACG.S58444","volume":"7","author":"D Buchbinder","year":"2014","unstructured":"Buchbinder D, Nugent DJ, Fillipovich AH. Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments. Appl Clin Genet. 2014;7:55\u201366.","journal-title":"Appl Clin Genet"},{"issue":"2","key":"797_CR47","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1182\/blood.V65.2.397.397","volume":"65","author":"LC Peterson","year":"1985","unstructured":"Peterson LC, Rao KV, Crosson JT, White JG. Fechtner syndrome\u2013a variant of Alport\u2019s syndrome with leukocyte inclusions and macrothrombocytopenia. Blood. 1985;65(2):397\u2013406.","journal-title":"Blood"},{"issue":"3","key":"797_CR48","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0002-9343(72)90017-4","volume":"52","author":"CJ Epstein","year":"1972","unstructured":"Epstein CJ, Sahud MA, Piel CF, Goodman JR, Bernfield MR, Kushner JH, et al. Hereditary macrothrombocytopathia, nephritis and deafness. Am J Med. 1972;52(3):299\u2013310.","journal-title":"Am J Med"},{"issue":"5","key":"797_CR49","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/BF01732878","volume":"61","author":"A Greinacher","year":"1990","unstructured":"Greinacher A, Nieuwenhuis HK, White JG. Sebastian platelet syndrome: a new variant of hereditary macrothrombocytopenia with leukocyte inclusions. Blut. 1990;61(5):282\u20138.","journal-title":"Blut"},{"issue":"3","key":"797_CR50","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/01.md.0000076006.64510.5c","volume":"82","author":"M Seri","year":"2003","unstructured":"Seri M, Pecci A, Di Bari F, Cusano R, Savino M, Panza E, et al. MYH9-related disease: May-hegglin anomaly, Sebastian syndrome, fechtner syndrome, and epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine (Baltimore). 2003;82(3):203\u201315.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"797_CR51","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1080\/09537104.2017.1294250","volume":"28","author":"A Savoia","year":"2017","unstructured":"Savoia A, De Rocco D, Pecci A. MYH9 gene mutations associated with bleeding. Platelets. 2017;28(3):312\u20135.","journal-title":"Platelets"},{"key":"797_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/cells9061458","author":"G Asensio-Ju\u00e1rez","year":"2020","unstructured":"Asensio-Ju\u00e1rez G, Llorente-Gonz\u00e1lez C, Vicente-Manzanares M. Linking the landscape of MYH9-related diseases to the molecular mechanisms that control non-muscle myosin II-A function in cells. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9061458.","journal-title":"Cells"},{"key":"797_CR53","unstructured":"Savoia APAIAM, Feldman J, Mirzaa GM, et al. editors. MYH9-Related Disease. 2008 Nov 20 [Updated 2021 Feb 18] GeneReviews\u00ae\u00a0Seattle (WA): University of Washington, Seattle1993-2024. Available from:https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK2689."},{"issue":"1","key":"797_CR54","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/humu.23927","volume":"41","author":"L Bury","year":"2020","unstructured":"Bury L, Megy K, Stephens JC, Grassi L, Greene D, Gleadall N, et al. Next-generation sequencing for the diagnosis of MYH9-RD: predicting pathogenic variants. Hum Mutat. 2020;41(1):277\u201390.","journal-title":"Hum Mutat"},{"issue":"S1","key":"797_CR55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5045\/br.2022.2021223","volume":"57","author":"B Kim","year":"2022","unstructured":"Kim B. Diagnostic workup of inherited platelet disorders. Blood Res. 2022;57(S1):11\u20139.","journal-title":"Blood Res"},{"issue":"2","key":"797_CR56","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1365-2141.2011.08716.x","volume":"154","author":"CL Balduini","year":"2011","unstructured":"Balduini CL, Pecci A, Savoia A. Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias. Br J Haematol. 2011;154(2):161\u201374.","journal-title":"Br J Haematol"},{"key":"797_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2024.1391742","volume":"12","author":"K Niwa","year":"2024","unstructured":"Niwa K, Toyoda H, Kohso A, Okumura Y, Kunishima S, Hirayama M. Case report: MYH9-related disease caused by Ala44Pro mutation in a child with a previous diagnosis of chronic immune thrombocytopenia. Front Pediatr. 2024;12:1391742.","journal-title":"Front Pediatr"},{"issue":"2","key":"797_CR58","volume":"16","author":"ZX Khor","year":"2024","unstructured":"Khor ZX, Liam CCK. MYH9-Related disorder (MYH9-RD): an under-recognized family of giants among the inherited thrombocytopenias. Cureus. 2024;16(2):e55174.","journal-title":"Cureus"},{"issue":"12","key":"797_CR59","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1111\/j.1538-7836.2009.03614.x","volume":"7","author":"P Noris","year":"2009","unstructured":"Noris P, Klersy C, Zecca M, Arcaini L, Pecci A, Melazzini F, et al. Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia. J Thromb Haemost. 2009;7(12):2131\u20136.","journal-title":"J Thromb Haemost"},{"issue":"3","key":"797_CR60","doi-asserted-by":"publisher","first-page":"575","DOI":"10.12669\/pjms.323.9456","volume":"32","author":"A Naz","year":"2016","unstructured":"Naz A, Mukry SN, Shaikh MR, Bukhari AR, Shamsi TS. Importance of immature platelet fraction as predictor of immune thrombocytopenic purpura. Pak J Med Sci. 2016;32(3):575\u20139.","journal-title":"Pak J Med Sci"},{"issue":"5","key":"797_CR61","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ejmg.2010.06.010","volume":"53","author":"S Vettore","year":"2010","unstructured":"Vettore S, De Rocco D, Gerber B, Scandellari R, Bianco AM, Balduini CL, et al. A g to C transversion at the last nucleotide of exon 25 of the MYH9 gene results in a missense mutation rather than in a splicing defect. Eur J Med Genet. 2010;53(5):256\u201360.","journal-title":"Eur J Med Genet"},{"issue":"4","key":"797_CR62","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/mgg3.68","volume":"2","author":"B Saposnik","year":"2014","unstructured":"Saposnik B, Binard S, Fenneteau O, Nurden A, Nurden P, Hurtaud-Roux MF, et al. Mutation spectrum and genotype-phenotype correlations in a large French cohort of MYH9-Related disorders. Mol Genet Genomic Med. 2014;2(4):297\u2013312.","journal-title":"Mol Genet Genomic Med"},{"key":"797_CR63","unstructured":"laboratories mc. Test information was obtained from the Mayo Clinic laboratories test catalog available at:\u00a0www.mayocliniclabs.com\/test-catalog\/overview\/619299#Performance."},{"issue":"8","key":"797_CR64","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1111\/j.1538-7836.2012.04805.x","volume":"10","author":"AC Glembotsky","year":"2012","unstructured":"Glembotsky AC, Marta RF, Pecci A, De Rocco D, Gnan C, Espasandin YR, et al. International collaboration as a tool for diagnosis of patients with inherited thrombocytopenia in the setting of a developing country. J Thromb Haemost. 2012;10(8):1653\u201361.","journal-title":"J Thromb Haemost"},{"issue":"7","key":"797_CR65","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1111\/jth.13729","volume":"15","author":"A Greinacher","year":"2017","unstructured":"Greinacher A, Pecci A, Kunishima S, Althaus K, Nurden P, Balduini CL, et al. Diagnosis of inherited platelet disorders on a blood smear: a tool to facilitate worldwide diagnosis of platelet disorders. J Thromb Haemost. 2017;15(7):1511\u201321.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"797_CR66","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.jtha.2022.12.031","volume":"21","author":"C Zaninetti","year":"2023","unstructured":"Zaninetti C, Lein\u00f8e E, Lozano ML, Rossing M, Bastida JM, Zetterberg E, et al. Validation of immunofluorescence analysis of blood smears in patients with inherited platelet disorders. J Thromb Haemost. 2023;21(4):1010\u20139.","journal-title":"J Thromb Haemost"},{"key":"797_CR67","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.gene.2018.04.048","volume":"664","author":"A Pecci","year":"2018","unstructured":"Pecci A, Ma X, Savoia A, Adelstein RS. MYH9: structure, functions and role of non-muscle myosin IIA in human disease. Gene. 2018;664:152\u201367.","journal-title":"Gene"},{"issue":"26","key":"797_CR68","doi-asserted-by":"publisher","first-page":"5832","DOI":"10.1182\/blood-2010-08-304725","volume":"116","author":"A Pecci","year":"2010","unstructured":"Pecci A, Gresele P, Klersy C, Savoia A, Noris P, Fierro T, et al. Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutations. Blood. 2010;116(26):5832\u20137.","journal-title":"Blood"},{"issue":"3","key":"797_CR69","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1053\/j.seminhematol.2006.04.003","volume":"43","author":"AE Geddis","year":"2006","unstructured":"Geddis AE. Inherited thrombocytopenia: congenital amegakaryocytic thrombocytopenia and thrombocytopenia with absent radii. Semin Hematol. 2006;43(3):196\u2013203.","journal-title":"Semin Hematol"},{"issue":"2","key":"797_CR70","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1046\/j.1365-2141.1997.d01-2028.x","volume":"96","author":"K Muraoka","year":"1997","unstructured":"Muraoka K, Ishii E, Tsuji K, Yamamoto S, Yamaguchi H, Hra T, et al. Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopenia. Br J Haematol. 1997;96(2):287\u201392.","journal-title":"Br J Haematol"},{"issue":"4","key":"797_CR71","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0609.2008.01029.x","volume":"80","author":"S Kanaji","year":"2008","unstructured":"Kanaji S, Kanaji T, Migita M, Kunishima S, Kunicki TJ, Okamura T, et al. Characterization of a patient with atypical amegakaryocytic thrombocytopenia. Eur J Haematol. 2008;80(4):361\u20134.","journal-title":"Eur J Haematol"},{"issue":"5","key":"797_CR72","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.3324\/haematol.2022.281392","volume":"108","author":"V Capaci","year":"2023","unstructured":"Capaci V, Adam E, Bar-Joseph I, Faleschini M, Pecci A, Savoia A. Defective binding of ETS1 and STAT4 due to a mutation in the promoter region of THPO as a novel mechanism of congenital amegakaryocytic thrombocytopenia. Haematologica. 2023;108(5):1385\u201393.","journal-title":"Haematologica"},{"issue":"1","key":"797_CR73","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2141.2009.07706.x","volume":"146","author":"M Ballmaier","year":"2009","unstructured":"Ballmaier M, Germeshausen M. Advances in the understanding of congenital amegakaryocytic thrombocytopenia. Br J Haematol. 2009;146(1):3\u201316.","journal-title":"Br J Haematol"},{"key":"797_CR74","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4137\/CPath.S4972","volume":"3","author":"FS Al-Qahtani","year":"2010","unstructured":"Al-Qahtani FS. Congenital amegakaryocytic thrombocytopenia: a brief review of the literature. Clin Med Insights Pathol. 2010;3:25\u201330.","journal-title":"Clin Med Insights Pathol"},{"issue":"6","key":"797_CR75","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1055\/s-0031-1291377","volume":"37","author":"M Ballmaier","year":"2011","unstructured":"Ballmaier M, Germeshausen M. Congenital amegakaryocytic thrombocytopenia: clinical presentation, diagnosis, and treatment. Semin Thromb Hemost. 2011;37(6):673\u201381.","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"797_CR76","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/j.1365-2141.2005.05819.x","volume":"131","author":"S King","year":"2005","unstructured":"King S, Germeshausen M, Strauss G, Welte K, Ballmaier M. Congenital amegakaryocytic thrombocytopenia: a retrospective clinical analysis of 20 patients. Br J Haematol. 2005;131(5):636\u201344.","journal-title":"Br J Haematol"},{"issue":"9","key":"797_CR77","doi-asserted-by":"publisher","first-page":"e341","DOI":"10.3324\/haematol.2015.125963","volume":"100","author":"M Ballmaier","year":"2015","unstructured":"Ballmaier M, Holter W, Germeshausen M. Flow cytometric detection of MPL (CD110) as a diagnostic tool for differentiation of congenital thrombocytopenias. Haematologica. 2015;100(9):e341-4.","journal-title":"Haematologica"},{"issue":"1","key":"797_CR78","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1182\/hematology.2021000246","volume":"2021","author":"A Narla","year":"2021","unstructured":"Narla A. When to worry about inherited bone marrow failure and myeloid malignancy predisposition syndromes in the setting of a hypocellular marrow. Hematology. 2021;2021(1):153\u20136.","journal-title":"Hematology"},{"issue":"4","key":"797_CR79","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000539","volume":"5","author":"E G\u00e1lvez","year":"2021","unstructured":"G\u00e1lvez E, Vallesp\u00edn E, Arias-Salgado EG, S\u00e1nchez-Valdepe\u00f1as C, Gim\u00e9nez Y, Navarro S, et al. Next-generation sequencing in bone marrow failure syndromes and isolated cytopenias: experience of the Spanish network on bone marrow failure syndromes. Hemasphere. 2021;5(4):e539.","journal-title":"Hemasphere"},{"key":"797_CR80","unstructured":"GeneDx. Test information Sheet. GeneDX DNA Diagnostic Experts. MPL gene analysis in congenital amegakaryocytic thrombocytopenia. 2021. Available from:\u00a0https:\/\/providers.genedx.com\/Resources\/TIS-Files\/TIS-TA47.pdf."},{"issue":"Supplement 1","key":"797_CR81","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-190490","volume":"142","author":"U Kapoor","year":"2023","unstructured":"Kapoor U, Kaicker S, Shek J, Gartrell R, Bhatia M. Two hit theory for the pathogenesis of type 3 congenital amegakaryocytic thrombocytopenia. Blood. 2023;142(Supplement 1):5454.","journal-title":"Blood"},{"issue":"9","key":"797_CR82","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.3324\/haematol.2020.257972","volume":"106","author":"G Manuela","year":"2021","unstructured":"Manuela G, Matthias B. CAMT-MPL: congenital amegakaryocytic thrombocytopenia caused by MPL mutations - heterogeneity of a monogenic disorder - a comprehensive analysis of 56 patients. Haematologica. 2021;106(9):2439\u201348.","journal-title":"Haematologica"},{"issue":"2","key":"797_CR83","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jtct.2021.10.009","volume":"28","author":"M Cancio","year":"2022","unstructured":"Cancio M, Hebert K, Kim S, Aljurf M, Olson T, Anderson E, et al. Outcomes in hematopoietic stem cell transplantation for congenital amegakaryocytic thrombocytopenia. Transplantation Cell Therapy. 2022;28(2):101. e1-. e6.","journal-title":"Transplantation Cell Therapy"},{"issue":"2","key":"797_CR84","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/jmg.24.2.79","volume":"24","author":"JG Hall","year":"1987","unstructured":"Hall JG. Thrombocytopenia and absent radius (TAR) syndrome. J Med Genet. 1987;24(2):79.","journal-title":"J Med Genet"},{"issue":"3","key":"797_CR85","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.gde.2013.02.015","volume":"23","author":"CA Albers","year":"2013","unstructured":"Albers CA, Newbury-Ecob R, Ouwehand WH, Ghevaert C. New insights into the genetic basis of TAR (thrombocytopenia-absent radii) syndrome. Curr Opin Genet Dev. 2013;23(3):316\u201323.","journal-title":"Curr Opin Genet Dev"},{"issue":"4","key":"797_CR86","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/bjh.14913","volume":"179","author":"G Manukjan","year":"2017","unstructured":"Manukjan G, B\u00f6sing H, Schmugge M, Strau\u00df G, Schulze H. Impact of genetic variants on haematopoiesis in patients with thrombocytopenia absent radii (TAR) syndrome. Br J Haematol. 2017;179(4):606\u201317.","journal-title":"Br J Haematol"},{"key":"797_CR87","doi-asserted-by":"crossref","unstructured":"Toriello HV. Thrombocytopenia-absent radius syndrome. Semin Thromb Hemost. 2011;37(6):707-12.","DOI":"10.1055\/s-0031-1291381"},{"issue":"2","key":"797_CR88","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.hoc.2009.01.012","volume":"23","author":"AE Geddis","year":"2009","unstructured":"Geddis AE. Congenital amegakaryocytic thrombocytopenia and thrombocytopenia with absent radii. Hematol Oncol Clin N Am. 2009;23(2):321\u201331.","journal-title":"Hematol Oncol Clin N Am"},{"issue":"2","key":"797_CR89","first-page":"612","volume":"90","author":"M Ballmaier","year":"1997","unstructured":"Ballmaier M, Schulze H, Strau\u03b2 G, Cherkaoui K, Wittner N, Lynen S, et al. Thrombopoietin in patients with congenital thrombocytopenia and absent radii: elevated serum levels, normal receptor expression, but defective reactivity to thrombopoietin. Blood J Am Soc Hematol. 1997;90(2):612\u20139.","journal-title":"Blood J Am Soc Hematol"},{"issue":"2","key":"797_CR90","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1046\/j.1365-2141.1998.00991.x","volume":"103","author":"P Strippoli","year":"1998","unstructured":"Strippoli P, Savoia A, Iolascon A, Tonelli R, Savino M, Giordano P, et al. Mutational screening of thrombopoietin receptor gene (c-mpl) in patients with congenital thrombocytopenia and absent radii (TAR). Br J Haematol. 1998;103(2):311\u20134.","journal-title":"Br J Haematol"},{"issue":"04","key":"797_CR91","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1055\/a-2088-1801","volume":"43","author":"G Strauss","year":"2023","unstructured":"Strauss G, Mott K, Klopocki E, Schulze H. Thrombocytopenia absent radius (TAR)-syndrome: from current genetics to patient self-empowerment. Hamostaseologie. 2023;43(04):252\u201360.","journal-title":"Hamostaseologie"},{"issue":"4","key":"797_CR92","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.blre.2008.03.004","volume":"22","author":"I Roberts","year":"2008","unstructured":"Roberts I, Stanworth S, Murray NA. Thrombocytopenia in the neonate. Blood Rev. 2008;22(4):173\u201386.","journal-title":"Blood Rev"},{"issue":"5","key":"797_CR93","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1097\/MS9.0000000000000506","volume":"85","author":"R Alassri","year":"2023","unstructured":"Alassri R, Martini N, Othman R, Kamil H, Mahmoud J. Thrombocytopenia with absent radii syndrome with delayed presentation of thrombocytopenic episodes: a case report. Ann Med Surg. 2023;85(5):2081\u20134.","journal-title":"Ann Med Surg"},{"issue":"2","key":"797_CR94","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1086\/510919","volume":"80","author":"E Klopocki","year":"2007","unstructured":"Klopocki E, Schulze H, Strau\u00df G, Ott C-E, Hall J, Trotier F, et al. Complex inheritance pattern resembling autosomal recessive inheritance involving a microdeletion in thrombocytopenia\u2013absent radius syndrome. Am J Hum Genet. 2007;80(2):232\u201340.","journal-title":"Am J Hum Genet"},{"key":"797_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23179621","author":"C Monteiro","year":"2022","unstructured":"Monteiro C, Gon\u00e7alves A, Oliveira J, Salvado R, Tomaz J, Morais S, et al. Thrombocytopenia-absent radius syndrome: descriptions of three new cases and a novel splicing variant in RBM8A that expands the spectrum of null alleles. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23179621.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"797_CR96","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/ijlh.12516","volume":"38","author":"E Nicchia","year":"2016","unstructured":"Nicchia E, Giordano P, Greco C, De Rocco D, Savoia A. Molecular diagnosis of thrombocytopenia-absent radius syndrome using next-generation sequencing. Int J Lab Hematol. 2016;38(4):412\u20138.","journal-title":"Int J Lab Hematol"},{"issue":"9","key":"797_CR97","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.clinbiochem.2014.04.018","volume":"47","author":"VR Yassaee","year":"2014","unstructured":"Yassaee VR, Hashemi-Gorji F, Soltani Z, Poorhosseini SM. A new approach for molecular diagnosis of TAR syndrome. Clin Biochem. 2014;47(9):835\u20139.","journal-title":"Clin Biochem"},{"issue":"2","key":"797_CR98","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1440-1754.2011.02069.x","volume":"48","author":"P Coccia","year":"2012","unstructured":"Coccia P, Ruggiero A, Mastrangelo S, Attin\u00e0 G, Scalzone M, Pittiruti M, et al. Management of children with thrombocytopenia-absent radius syndrome: an institutional experience. J Paediatr Child Health. 2012;48(2):166\u20139.","journal-title":"J Paediatr Child Health"},{"issue":"1","key":"797_CR99","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/os.12157","volume":"7","author":"A Al Kaissi","year":"2015","unstructured":"Al Kaissi A, Girsch W, Kenis V, Melchenko E, Ben Ghachem M, Pospischill R, et al. Reconstruction of limb deformities in patients with thrombocytopenia-absent radius syndrome. Orthop Surg. 2015;7(1):50\u20136.","journal-title":"Orthop Surg"},{"key":"797_CR100","volume":"130","author":"N Gallastegui","year":"2017","unstructured":"Gallastegui N, Dudkiewicz PB, Jy W, Horstman LL, Ahn YS. Romiplostim (Nplate\u00ae) and oprelvekin (Neumega\u00ae) correct thrombocytopenia in TAR syndrome (thrombocytopenia with absent radii). Blood. 2017;130:4953.","journal-title":"Blood"},{"issue":"5","key":"797_CR101","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1182\/blood-2014-08-594531","volume":"125","author":"R Bottega","year":"2015","unstructured":"Bottega R, Marconi C, Faleschini M, Baj G, Cagioni C, Pecci A, et al. ACTN1-related thrombocytopenia: identification of novel families for phenotypic characterization. Blood. 2015;125(5):869\u201372.","journal-title":"Blood"},{"issue":"8","key":"797_CR102","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1182\/blood-2012-04-408724","volume":"120","author":"JN Thon","year":"2012","unstructured":"Thon JN, Italiano JE Jr. Does size matter in platelet production? Blood. 2012;120(8):1552\u201361.","journal-title":"Blood"},{"issue":"8","key":"797_CR103","doi-asserted-by":"publisher","first-page":"e515","DOI":"10.1097\/MPH.0000000000000885","volume":"39","author":"H Boutroux","year":"2017","unstructured":"Boutroux H, David B, Gu\u00e9guen P, Frange P, Vincenot A, Leverger G, et al. ACTN1-related macrothrombocytopenia: A novel entity in the progressing field of pediatric thrombocytopenia. J Pediatr Hematol Oncol. 2017;39(8):e515\u20138.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"12","key":"797_CR104","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1002\/humu.23840","volume":"40","author":"A Vincenot","year":"2019","unstructured":"Vincenot A, Saultier P, Kunishima S, Poggi M, Hurtaud-Roux MF, Roussel A, et al. Novel ACTN1 variants in cases of thrombocytopenia. Hum Mutat. 2019;40(12):2258\u201369.","journal-title":"Hum Mutat"},{"issue":"13","key":"797_CR105","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1242\/jcs.111.13.1813","volume":"111","author":"M Gimona","year":"1998","unstructured":"Gimona M, Mital R. The single CH domain of Calponin is neither sufficient nor necessary for F-actin binding. J Cell Sci. 1998;111(13):1813\u201321.","journal-title":"J Cell Sci"},{"issue":"6","key":"797_CR106","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/1873-3468.12101","volume":"590","author":"AC Murphy","year":"2016","unstructured":"Murphy AC, Lindsay AJ, McCaffrey MW, Djinovi\u0107-Carugo K, Young PW. Congenital macrothrombocytopenia\u2010linked mutations in the actin\u2010binding domain of \u03b1\u2010actinin\u20101 enhance F\u2010actin association. FEBS Lett. 2016;590(6):685\u201395.","journal-title":"FEBS Lett"},{"key":"797_CR107","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1007\/s00018-008-8080-8","volume":"65","author":"B Sj\u00f6blom","year":"2008","unstructured":"Sj\u00f6blom B, Salmazo A, Djinovi\u0107-Carugo K. \u03b1-Actinin structure and regulation. Cell Mol Life Sci. 2008;65:2688\u2013701.","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"797_CR108","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ajhg.2013.01.015","volume":"92","author":"S Kunishima","year":"2013","unstructured":"Kunishima S, Okuno Y, Yoshida K, Shiraishi Y, Sanada M, Muramatsu H, et al. ACTN1 mutations cause congenital macrothrombocytopenia. Am J Hum Genet. 2013;92(3):431\u20138.","journal-title":"Am J Hum Genet"},{"issue":"12","key":"797_CR109","doi-asserted-by":"publisher","first-page":"e27418","DOI":"10.1002\/pbc.27418","volume":"65","author":"D Kanhai","year":"2018","unstructured":"Kanhai D, Mulder R, Ploos van Amstel HK, Schutgens R, Lukens M, Tamminga RY. Familial macrothrombocytopenia due to a double mutation in Cis in the alpha-actinin 1 gene (ACTN1), previously considered to be chronic immune thrombocytopenic purpura. Pediatr Blood Cancer. 2018;65(12):e27418.","journal-title":"Pediatr Blood Cancer"},{"issue":"22","key":"797_CR110","first-page":"2525","volume":"126","author":"S Kunishima","year":"2015","unstructured":"Kunishima S, Kitamura K, Yasutomi M, Kobayashi R. Diagnostic biomarker for ACTN1 macrothrombocytopenia. Blood. J Am Soc Hematol. 2015;126(22):2525\u20136.","journal-title":"J Am Soc Hematol"},{"issue":"9","key":"797_CR111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074728","volume":"8","author":"P Gu\u00e9guen","year":"2013","unstructured":"Gu\u00e9guen P, Rouault K, Chen J-M, Ragu\u00e9n\u00e8s O, Fichou Y, Hardy E, et al. A missense mutation in the alpha-actinin 1 gene (ACTN1) is the cause of autosomal dominant macrothrombocytopenia in a large French family. PLoS One. 2013;8(9):e74728.","journal-title":"PLoS One"},{"key":"797_CR112","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.679279","volume":"9","author":"F-M Luo","year":"2021","unstructured":"Luo F-M, Fan L-L, Sheng Y, Dong Y, Liu L. Case report: exome sequencing identified a novel frameshift mutation of \u03b1-actin 1 in a Chinese family with macrothrombocytopenia and mild bleeding. Front Pediatr. 2021;9:679279.","journal-title":"Front Pediatr"},{"key":"797_CR113","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19457","author":"ME Zanchetta","year":"2024","unstructured":"Zanchetta ME, Barozzi S, Isidori F, Marconi C, Farinasso L, Bottega R, et al. ACTN1-related thrombocytopenia: homozygosity for an ACTN1 variant results in a more severe phenotype. Br J Haematol. 2024. https:\/\/doi.org\/10.1111\/bjh.19457.","journal-title":"Br J Haematol"},{"issue":"23","key":"797_CR114","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1182\/blood-2015-12-688267","volume":"127","author":"I Simeoni","year":"2016","unstructured":"Simeoni I, Stephens JC, Hu F, Deevi SV, Megy K, Bariana TK, et al. A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders. Blood. 2016;127(23):2791\u2013803.","journal-title":"Blood"},{"issue":"6","key":"797_CR115","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1080\/09537104.2017.1356455","volume":"28","author":"SK Westbury","year":"2017","unstructured":"Westbury SK, Shoemark DK, Mumford AD. ACTN1 variants associated with thrombocytopenia. Platelets. 2017;28(6):625\u20137.","journal-title":"Platelets"},{"key":"797_CR116","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.ijbiomac.2019.06.180","volume":"136","author":"R Santucci","year":"2019","unstructured":"Santucci R, Sinibaldi F, Cozza P, Polticelli F, Fiorucci L. Cytochrome c: an extreme multifunctional protein with a key role in cell fate. Int J Biol Macromol. 2019;136:1237\u201346.","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"797_CR117","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/ng.103","volume":"40","author":"IM Morison","year":"2008","unstructured":"Morison IM, Cramer Bord\u00e9 EM, Cheesman EJ, Cheong PL, Holyoake AJ, Fichelson S, et al. A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia. Nat Genet. 2008;40(4):387\u20139.","journal-title":"Nat Genet"},{"issue":"2","key":"797_CR118","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.bbadis.2013.12.002","volume":"1842","author":"D De Rocco","year":"2014","unstructured":"De Rocco D, Cerqua C, Goffrini P, Russo G, Pastore A, Meloni F, et al. Mutations of cytochrome c identified in patients with thrombocytopenia THC4 affect both apoptosis and cellular bioenergetics. Biochimica et biophysica acta (BBA)-Molecular basis of disease. 2014;1842(2):269\u201374.","journal-title":"Biochimica et biophysica acta (BBA)-Molecular basis of disease"},{"issue":"6","key":"797_CR119","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/cge.13423","volume":"94","author":"Y Uchiyama","year":"2018","unstructured":"Uchiyama Y, Yanagisawa K, Kunishima S, Shiina M, Ogawa Y, Nakashima M, et al. A novel CYCS mutation in the \u03b1-helix of the CYCS c\u2010terminal domain causes non\u2010syndromic thrombocytopenia. Clin Genet. 2018;94(6):548\u201353.","journal-title":"Clin Genet"},{"issue":"7814","key":"797_CR120","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41586-020-2434-2","volume":"583","author":"E Turro","year":"2020","unstructured":"Turro E, Astle WJ, Megy K, Gr\u00e4f S, Greene D, Shamardina O, et al. Whole-genome sequencing of patients with rare diseases in a National health system. Nature. 2020;583(7814):96\u2013102.","journal-title":"Nature"},{"issue":"2","key":"797_CR121","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/bjh.14421","volume":"176","author":"L Ong","year":"2017","unstructured":"Ong L, Morison IM, Ledgerwood EC. Megakaryocytes from CYCS mutation-associated thrombocytopenia release platelets by both proplatelet\u2010dependent and\u2010independent processes. Br J Haematol. 2017;176(2):268\u201379.","journal-title":"Br J Haematol"},{"key":"797_CR122","doi-asserted-by":"crossref","unstructured":"Cramer Bord\u00e9 E, Ouzegdouh Y, Ledgerwood EC, Morison IM. Congenital thrombocytopenia and cytochrome C mutation: a matter of birth and death. Semin Thromb Hemost. 2011;37(6):664-72.","DOI":"10.1055\/s-0031-1291376"},{"issue":"4","key":"797_CR123","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/rth2.12151","volume":"2","author":"B Johnson","year":"2018","unstructured":"Johnson B, Doak R, Allsup D, Astwood E, Evans G, Grimley C, et al. A comprehensive targeted next-generation sequencing panel for genetic diagnosis of patients with suspected inherited thrombocytopenia. Res Pract Thromb Haemost. 2018;2(4):640\u201352.","journal-title":"Res Pract Thromb Haemost"},{"issue":"7","key":"797_CR124","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1182\/blood-2005-02-0723","volume":"106","author":"K Freson","year":"2005","unstructured":"Freson K, De Vos R, Wittevrongel C, Thys C, Defoor J, Vanhees L, et al. The TUBB1 Q43P functional polymorphism reduces the risk of cardiovascular disease in men by modulating platelet function and structure. Blood. 2005;106(7):2356\u201362.","journal-title":"Blood"},{"issue":"D1","key":"797_CR125","doi-asserted-by":"publisher","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","volume":"42","author":"MJ Landrum","year":"2014","unstructured":"Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42(D1):D980\u20135.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"797_CR126","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0960-9822(01)00153-1","volume":"11","author":"HD Schwer","year":"2001","unstructured":"Schwer HD, Lecine P, Tiwari S, Italiano JE Jr., Hartwig JH, Shivdasani RA. A lineage-restricted and divergent beta-tubulin isoform is essential for the biogenesis, structure and function of blood platelets. Curr Biol. 2001;11(8):579\u201386.","journal-title":"Curr Biol"},{"issue":"2","key":"797_CR127","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1182\/blood-2008-06-162610","volume":"113","author":"S Kunishima","year":"2009","unstructured":"Kunishima S, Kobayashi R, Itoh TJ, Hamaguchi M, Saito H. Mutation of the \u03b21-tubulin gene associated with congenital macrothrombocytopenia affecting microtubule assembly. Blood. 2009;113(2):458\u201361.","journal-title":"Blood"},{"key":"797_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2019.00080","volume":"6","author":"I Almazni","year":"2019","unstructured":"Almazni I, Stapley R, Morgan NV. Inherited thrombocytopenia: update on genes and genetic variants which may be associated with bleeding. Front Cardiovasc Med. 2019;6:80.","journal-title":"Front Cardiovasc Med"},{"issue":"24","key":"797_CR129","doi-asserted-by":"publisher","first-page":"5453","DOI":"10.1182\/bloodadvances.2020004057","volume":"5","author":"V Palma-Barqueros","year":"2021","unstructured":"Palma-Barqueros V, Bury L, Kunishima S, Lozano ML, Rodr\u00edguez-Alen A, Revilla N, et al. Expanding the genetic spectrum of TUBB1-related thrombocytopenia. Blood Adv. 2021;5(24):5453\u201367.","journal-title":"Blood Adv"},{"issue":"2","key":"797_CR130","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3906\/sag-2003-259","volume":"51","author":"ZO \u00c7al\u0131\u015fkaner","year":"2021","unstructured":"\u00c7al\u0131\u015fkaner ZO, Abdul Waheed A, Tuzlako\u011flu \u00d6zt\u00fcrk M, Oymak Y, Tazebay UH, Akar N, et al. Identification of novel TUBB1 variants in patients with macrothrombocytopenia. Turk J Med Sci. 2021;51(2):490\u2013500.","journal-title":"Turk J Med Sci"},{"issue":"Suppl 1","key":"797_CR131","first-page":"S18","volume":"35","author":"J St\u00e4chele","year":"2015","unstructured":"St\u00e4chele J, Bakchoul T, Najm J, Felbor U, Kn\u00f6fler R. Congenital macrothrombocytopenia associated with a combination of functional polymorphisms in the TUBB1 gene. Hamostaseologie. 2015;35(Suppl 1):S18-21.","journal-title":"Hamostaseologie"},{"issue":"8","key":"797_CR132","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1080\/09537104.2020.1869714","volume":"32","author":"Y Hou","year":"2021","unstructured":"Hou Y, Shao L, Zhou H, Liu Y, Fisk DG, Spiteri E, et al. Identification of a pathogenic TUBB1 variant in a Chinese family with congenital macrothrombocytopenia through whole genome sequencing. Platelets. 2021;32(8):1108\u201312.","journal-title":"Platelets"},{"key":"797_CR133","unstructured":"\u00d6zkan D, Waheed A, Kandilci A, Akar A. N. First observation og TUBB1 gene mutations in Turkish patients with macrothrombocytopenia. 2016."},{"issue":"2","key":"797_CR134","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/cge.12603","volume":"89","author":"A Pecci","year":"2016","unstructured":"Pecci A. Diagnosis and treatment of inherited thrombocytopenias. Clin Genet. 2016;89(2):141\u201353.","journal-title":"Clin Genet"},{"issue":"SUPPL 1","key":"797_CR135","first-page":"734","volume":"4","author":"M Jiang","year":"2020","unstructured":"Jiang M, Sheng G, Yin J, Wang X, Yu Z, Ruan C. Refractory thrombocytopenia with tubb1 variants: clinical features and responses to Eltrombopag treatment. Res Pract Thromb Haemost. 2020;4(SUPPL 1):734\u20135.","journal-title":"Res Pract Thromb Haemost"},{"issue":"2","key":"797_CR136","first-page":"145","volume":"43","author":"A Yokota","year":"2020","unstructured":"Yokota A, Huo L, Lan F, Wu J, Huang G. The clinical, molecular, and mechanistic basis of RUNX1 mutations identified in hematological malignancies. Mol Cells. 2020;43(2):145\u201352.","journal-title":"Mol Cells"},{"issue":"3","key":"797_CR137","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nm997","volume":"10","author":"M Ichikawa","year":"2004","unstructured":"Ichikawa M, Asai T, Saito T, Yamamoto G, Seo S, Yamazaki I, et al. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat Med. 2004;10(3):299\u2013304.","journal-title":"Nat Med"},{"issue":"6","key":"797_CR138","doi-asserted-by":"publisher","first-page":"720","DOI":"10.4161\/cc.3.6.951","volume":"3","author":"M Ichikawa","year":"2004","unstructured":"Ichikawa M, Asai T, Chiba S, Kurokawa M, Ogawa S. Runx1\/AML-1 ranks as a master regulator of adult hematopoiesis. Cell Cycle. 2004;3(6):720\u20132.","journal-title":"Cell Cycle"},{"key":"797_CR139","unstructured":"Cunningham NDEB. L ea. RUNX1 Familial Platelet Disorder with Associated Myeloid Malignancies. In: Adam MP, Feldman J, Mirzaa GM, editors. GeneReviews\u00ae. Seattle (WA), University of Washington, Seattle. 1993-2024. 2021 Mar 4. Available from:\u00a0https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK568319\/. Updated 11 Jan 2024."},{"issue":"2","key":"797_CR140","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1053\/j.seminhematol.2017.04.006","volume":"54","author":"B Schlegelberger","year":"2017","unstructured":"Schlegelberger B, Heller PG. RUNX1 deficiency (familial platelet disorder with predisposition to myeloid leukemia, FPDMM). Semin Hematol. 2017;54(2):75\u201380.","journal-title":"Semin Hematol"},{"issue":"25","key":"797_CR141","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1182\/blood.2023019746","volume":"142","author":"L Cunningham","year":"2023","unstructured":"Cunningham L, Merguerian M, Calvo KR, Davis J, Deuitch NT, Dulau-Florea A, et al. Natural history study of patients with familial platelet disorder with associated myeloid malignancy. Blood. 2023;142(25):2146\u201358.","journal-title":"Blood"},{"issue":"7","key":"797_CR142","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022;36(7):1703\u201319.","journal-title":"Leukemia"},{"issue":"3","key":"797_CR143","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s12185-023-03575-1","volume":"118","author":"K Toratani","year":"2023","unstructured":"Toratani K, Watanabe M, Kanda J, Oka T, Hyuga M, Arai Y, et al. Unrelated hematopoietic stem cell transplantation for familial platelet disorder\/acute myeloid leukemia with germline RUNX1 mutations. Int J Hematol. 2023;118(3):400\u20135.","journal-title":"Int J Hematol"},{"issue":"10","key":"797_CR144","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1080\/10428194.2022.2067997","volume":"63","author":"M Engvall","year":"2022","unstructured":"Engvall M, Karlsson Y, Kuchinskaya E, J\u00f6rnegren \u00c5, Mathot L, Pandzic T, et al. Familial platelet disorder due to germline exonic deletions in RUNX1: a diagnostic challenge with distinct alterations of the transcript isoform equilibrium. Leuk Lymphoma. 2022;63(10):2311\u201320.","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"797_CR145","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/jha2.594","volume":"4","author":"C Liu","year":"2023","unstructured":"Liu C, Ballerini P, Nguyen G, Mincheva Z, Copin B, Bouslama B, et al. Germline RUNX1 variants in paediatric patients in a French specialised centre. EJHaem. 2023;4(1):145\u201352.","journal-title":"EJHaem"},{"issue":"6","key":"797_CR146","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1182\/bloodadvances.2019000901","volume":"4","author":"AL Brown","year":"2020","unstructured":"Brown AL, Arts P, Carmichael CL, Babic M, Dobbins J, Chong C-E, et al. RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML. Blood Adv. 2020;4(6):1131\u201344.","journal-title":"Blood Adv"},{"issue":"2","key":"797_CR147","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1080\/09537104.2021.1887470","volume":"33","author":"I Almazni","year":"2022","unstructured":"Almazni I, Chudakou P, Dawson-Meadows A, Downes K, Freson K, Mason J, et al. A novel RUNX1 exon 3\u20137 deletion causing a familial platelet disorder. Platelets. 2022;33(2):320\u20133.","journal-title":"Platelets"},{"issue":"21","key":"797_CR148","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1093\/bioinformatics\/bts526","volume":"28","author":"V Plagnol","year":"2012","unstructured":"Plagnol V, Curtis J, Epstein M, Mok KY, Stebbings E, Grigoriadou S, et al. A robust model for read count data in exome sequencing experiments and implications for copy number variant calling. Bioinformatics. 2012;28(21):2747\u201354.","journal-title":"Bioinformatics"},{"issue":"9","key":"797_CR149","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1038\/leu.2012.79","volume":"26","author":"A Buijs","year":"2012","unstructured":"Buijs A, Poot M, van der Crabben S, van der Zwaag B, van Binsbergen E, van Roosmalen MJ, et al. Elucidation of a novel pathogenomic mechanism using genome-wide long mate-pair sequencing of a congenital t(16;21) in a series of three RUNX1-mutated FPD\/AML pedigrees. Leukemia. 2012;26(9):2151\u20134.","journal-title":"Leukemia"},{"key":"797_CR150","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cancergen.2018.01.002","volume":"222","author":"MC de Andrade Silva","year":"2018","unstructured":"de Andrade Silva MC, Krepischi ACV, Kulikowski LD, Zanardo EA, Nardinelli L, Leal AM, et al. Deletion of RUNX1 exons 1 and 2 associated with Familial platelet disorder with propensity to acute myeloid leukemia. Cancer Genet. 2018;222:32\u20137.","journal-title":"Cancer Genet"},{"issue":"4","key":"797_CR151","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2017-02-735290","volume":"130","author":"LA Godley","year":"2017","unstructured":"Godley LA, Shimamura A. Genetic predisposition to hematologic malignancies: management and surveillance. Blood. 2017;130(4):424\u201332.","journal-title":"Blood"},{"issue":"4","key":"797_CR152","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10689-021-00263-z","volume":"20","author":"B Schlegelberger","year":"2021","unstructured":"Schlegelberger B, Mecucci C, Wlodarski M. Review of guidelines for the identification and clinical care of patients with genetic predisposition for hematological malignancies. Fam Cancer. 2021;20(4):295\u2013303.","journal-title":"Fam Cancer"},{"issue":"11","key":"797_CR153","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1158\/1078-0432.CCR-17-0428","volume":"23","author":"CC Porter","year":"2017","unstructured":"Porter CC, Druley TE, Erez A, Kuiper RP, Onel K, Schiffman JD, et al. Recommendations for surveillance for children with leukemia-predisposing conditions. Clin Cancer Res. 2017;23(11):e14\u201322.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"797_CR154","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1182\/blood.2022017561","volume":"141","author":"K Lee","year":"2023","unstructured":"Lee K, Ahn HS, Estevez B, Poncz M. RUNX1-deficient human megakaryocytes demonstrate thrombopoietic and platelet half-life and functional defects. Blood. 2023;141(3):260\u201370.","journal-title":"Blood"},{"issue":"12","key":"797_CR155","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.1182\/blood-2008-05-156745","volume":"112","author":"CJ Owen","year":"2008","unstructured":"Owen CJ, Toze CL, Koochin A, Forrest DL, Smith CA, Stevens JM, et al. Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy. Blood. 2008;112(12):4639\u201345.","journal-title":"Blood"},{"issue":"7","key":"797_CR156","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1182\/blood.V75.7.1383.1383","volume":"75","author":"JN George","year":"1990","unstructured":"George JN, Caen JP, Nurden AT. Glanzmann\u2019s thrombasthenia: the spectrum of clinical disease. Blood. 1990;75(7):1383\u201395.","journal-title":"Blood"},{"key":"797_CR157","doi-asserted-by":"publisher","first-page":"581","DOI":"10.2147\/JBM.S273053","volume":"12","author":"A Nurden","year":"2021","unstructured":"Nurden A. Profiling the genetic and molecular characteristics of Glanzmann thrombasthenia: can it guide current and future therapies? J Blood Med. 2021;12:581\u201399.","journal-title":"J Blood Med"},{"issue":"5","key":"797_CR158","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3109\/09537104.2011.556275","volume":"22","author":"A Farsinejad","year":"2011","unstructured":"Farsinejad A, Abolghasemi H, Kazemi A, Aghaiipour M, Hadjati E, Faranoush M, et al. Classification of Iranian patients with Glanzmann\u2019s thrombasthenia using a flow cytometric method. Platelets. 2011;22(5):321\u20137.","journal-title":"Platelets"},{"issue":"1","key":"797_CR159","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MBC.0000000000000660","volume":"29","author":"S Tabibian","year":"2018","unstructured":"Tabibian S, Motlagh H, Naderi M, Dorgalaleh A. Intracranial hemorrhage in congenital bleeding disorders. Blood Coagul Fibrinolysis. 2018;29(1):1\u201311.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"797_CR160","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19528","author":"A Rottenstreich","year":"2024","unstructured":"Rottenstreich A, Coller BS. Pregnancy and childbirth in patients with Glanzmann thrombasthenia. Br J Haematol. 2024. https:\/\/doi.org\/10.1111\/bjh.19528.","journal-title":"Br J Haematol"},{"key":"797_CR161","doi-asserted-by":"crossref","unstructured":"Poon M-C, Safdari SM. Glanzmann thrombasthenia: diagnosis and management. Congenital bleeding disorders: diagnosis and management. Springer. 2023. p. 379\u2013422.","DOI":"10.1007\/978-3-031-43156-2_15"},{"issue":"6","key":"797_CR162","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/MBC.0b013e328360a558","volume":"24","author":"A Farsinejad","year":"2013","unstructured":"Farsinejad A, Farajollahi MM, Kazemi A, Saemi N, Faranoush M. Different biochemical expression pattern of platelet surface glycoproteins suggests molecular diversity of Glanzmann\u2019s thrombasthenia in Iran. Blood Coagul Fibrinolysis. 2013;24(6):613\u20138.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"797_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2021.102560","volume":"89","author":"N Rosenberg","year":"2021","unstructured":"Rosenberg N, Dardik R, Hauschner H, Nakav S, Barel O, Luboshitz J, et al. Mutations in RASGRP2 gene identified in patients misdiagnosed as Glanzmann thrombasthenia patients. Blood Cells Mol Dis. 2021;89:102560.","journal-title":"Blood Cells Mol Dis"},{"issue":"12","key":"797_CR164","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1016\/j.jtha.2023.08.012","volume":"21","author":"J Zhang","year":"2023","unstructured":"Zhang J, Tang J, Li G, Li N, Wang J, Yao R, et al. SINE-VNTR-Alu retrotransposon insertion as a novel mutational event underlying Glanzmann thrombasthenia. J Thromb Haemost. 2023;21(12):3597\u2013607.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"797_CR165","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.hemonc.2021.01.003","volume":"15","author":"A Alharbi","year":"2022","unstructured":"Alharbi A, Hashmi JA, Alharby E, Albalawi AM, Ramzan K, Basit S. A novel frameshift mutation in the ITGB3 gene leading to glanzmann\u2019s thrombasthenia in a Saudi Arabian family. Hematol Oncol Stem Cell Ther. 2022;15(1):21\u20136.","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"8","key":"797_CR166","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3109\/09537104.2014.998994","volume":"26","author":"H Tokgoz","year":"2015","unstructured":"Tokgoz H, Torun Ozkan D, Caliskan U, Akar N. Novel mutations of integrin \u03b1IIb and \u03b23 genes in Turkish children with glanzmann\u2019s thrombasthenia. Platelets. 2015;26(8):779\u201382.","journal-title":"Platelets"},{"issue":"1","key":"797_CR167","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1042-4","volume":"14","author":"F Zafarghandi Motlagh","year":"2019","unstructured":"Zafarghandi Motlagh F, Fallah MS, Bagherian H, Shirzadeh T, Ghasri S, Dabbagh S, et al. Molecular genetic diagnosis of Glanzmann syndrome in Iranian population; reporting novel and recurrent mutations. Orphanet J Rare Dis. 2019;14(1):87.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"797_CR168","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3906\/sag-2006-107","volume":"51","author":"B Saraymen","year":"2021","unstructured":"Saraymen B, Muhtaro\u011flu S, K\u00f6ker MY, Sarper N, Zengin E, Albayrak C, et al. Flow cytometric analysis of platelet surface glycoproteins in the diagnosis of thirty-two Turkish patients with Glanzmann thrombasthenia: a multicenter experience. Turk J Med Sci. 2021;51(4):2135\u201341.","journal-title":"Turk J Med Sci"},{"issue":"2","key":"797_CR169","first-page":"106","volume":"47","author":"B Kutlubay","year":"2012","unstructured":"Kutlubay B, \u00d6zdemir GN, T\u00fcys\u00fcz G, Apak H, Celkan T. Glanzmann thrombasthenia: Cerrahpa\u015fa medical faculty experience. Turk Arch Pediatr. 2012;47(2):106\u20138.","journal-title":"Turk Arch Pediatr"},{"issue":"3","key":"797_CR170","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/MBC.0b013e328330e683","volume":"21","author":"C Depner","year":"2010","unstructured":"Depner C, Schmid R, Kirchhoff P, Oertli D. Perioperative management of Glanzmann\u2019s syndrome: how we did it! Blood Coagul Fibrinolysis. 2010;21(3):283\u20134.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"12","key":"797_CR171","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1160\/TH09-04-0225","volume":"102","author":"G Di Minno","year":"2009","unstructured":"Di Minno G, Coppola A, Di Minno MN, Poon M-C. Glanzmann\u2019s thrombasthenia (defective platelet integrin \u03b1IIb-\u03b23): proposals for management between evidence and open issues. Thromb Haemost. 2009;102(12):1157\u201364.","journal-title":"Thromb Haemost"},{"issue":"2","key":"797_CR172","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.tmrv.2016.01.001","volume":"30","author":"MC Poon","year":"2016","unstructured":"Poon MC, Di Minno G, d\u2019Oiron R, Zotz R. New insights into the treatment of Glanzmann thrombasthenia. Transfus Med Rev. 2016;30(2):92\u20139.","journal-title":"Transfus Med Rev"},{"key":"797_CR173","doi-asserted-by":"crossref","unstructured":"Alberelli MA, Bacci M, Marchetti M, et al. Rituximab for treatment of autoimmune acquired platelet function disorders: description of two cases of acquired Glanzmann thrombasthenia and one case of acquired delta storage pool disease. Br J Haematol. 2019;187(5):e87-e91","DOI":"10.1111\/bjh.16243"},{"issue":"7","key":"797_CR174","doi-asserted-by":"publisher","first-page":"702","DOI":"10.3109\/09537104.2014.987225","volume":"26","author":"A Walz","year":"2015","unstructured":"Walz A, Lenzen A, Curtis B, Canner J, Schneiderman J. Use of allogeneic stem cell transplantation for moderate-severe Glanzmann thrombasthenia. Platelets. 2015;26(7):702\u20134.","journal-title":"Platelets"},{"issue":"3","key":"797_CR175","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/1753495X211067119","volume":"16","author":"U Demirci","year":"2023","unstructured":"Demirci U, Erbilen EA, \u00dcmit EG, \u0130nan C, Say\u0131n NC, Demir AM. Successful pregnancy and delivery management in a patient with Bernard soulier syndrome. Obstet Med. 2023;16(3):203\u20135.","journal-title":"Obstet Med"},{"issue":"12","key":"797_CR176","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1182\/blood.V91.12.4397","volume":"91","author":"JA L\u00f3pez","year":"1998","unstructured":"L\u00f3pez JA, Andrews RK, Afshar-Kharghan V, Berndt MC. Bernard-Soulier syndrome. Blood. 1998;91(12):4397\u2013418.","journal-title":"Blood"},{"issue":"3","key":"797_CR177","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00277-013-1895-x","volume":"93","author":"S Ali","year":"2014","unstructured":"Ali S, Ghosh K, Shetty S. Novel genetic abnormalities in Bernard-Soulier syndrome in India. Ann Hematol. 2014;93(3):381\u20134.","journal-title":"Ann Hematol"},{"issue":"4","key":"797_CR178","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/BF02982690","volume":"76","author":"S Kunishima","year":"2002","unstructured":"Kunishima S, Kamiya T, Saito H. Genetic abnormalities of Bernard-Soulier syndrome. Int J Hematol. 2002;76(4):319\u201327.","journal-title":"Int J Hematol"},{"issue":"6","key":"797_CR179","doi-asserted-by":"publisher","first-page":"e510","DOI":"10.1111\/hae.12777","volume":"21","author":"S Okoli","year":"2015","unstructured":"Okoli S, Madan B, Mwirigi A, Moore G, Drew A, Mitchell MJ, et al. A diagnostic dilemma: variant Bernard\u2013Soulier syndrome, a difficult clinical and genetic diagnosis. Haemophilia. 2015;21(6):e510-3.","journal-title":"Haemophilia"},{"issue":"1","key":"797_CR180","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2024.2334642","volume":"29","author":"S Zhang","year":"2024","unstructured":"Zhang S, Ling J, Cui K, Zhan S, Zheng J, Wang W, et al. Bernard-soulier syndrome caused by two novel heterozygous GP1BA gene mutations: a case report and literature review. Hematology. 2024;29(1):2334642.","journal-title":"Hematology"},{"issue":"9","key":"797_CR181","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/humu.22607","volume":"35","author":"A Savoia","year":"2014","unstructured":"Savoia A, Kunishima S, De Rocco D, Zieger B, Rand ML, Pujol-Moix N, et al. Spectrum of the mutations in Bernard\u2013Soulier syndrome. Hum Mutat. 2014;35(9):1033\u201345.","journal-title":"Hum Mutat"},{"issue":"8","key":"797_CR182","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.7767","volume":"11","author":"I Effendi","year":"2023","unstructured":"Effendi I, Nadeem A, Sarfraz S, Shahid M, Farooq M, Anand A. Bernard Soulier syndrome: a case report from Pakistan. Clin Case Rep. 2023;11(8):e7767.","journal-title":"Clin Case Rep"},{"issue":"11","key":"797_CR183","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.3324\/haematol.12830","volume":"93","author":"S Vettore","year":"2008","unstructured":"Vettore S, Scandellari R, Moro S, Lombardi AM, Scapin M, Randi ML, et al. Novel point mutation in a leucine-rich repeat of the GPIbalpha chain of the platelet von Willebrand factor receptor, GPIb\/IX\/V, resulting in an inherited dominant form of Bernard-Soulier syndrome affecting two unrelated families: the N41H variant. Haematologica. 2008;93(11):1743\u20137.","journal-title":"Haematologica"},{"issue":"5","key":"797_CR184","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/bjh.15409","volume":"182","author":"JD Grainger","year":"2018","unstructured":"Grainger JD, Thachil J, Will AM. How we treat the platelet glycoprotein defects; Glanzmann thrombasthenia and Bernard soulier syndrome in children and adults. Br J Haematol. 2018;182(5):621\u201332.","journal-title":"Br J Haematol"},{"issue":"12","key":"797_CR185","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.5858\/2007-131-1834-BSAIPD","volume":"131","author":"A Pham","year":"2007","unstructured":"Pham A, Wang J. Bernard-Soulier syndrome: an inherited platelet disorder. Arch Pathol Lab Med. 2007;131(12):1834\u20136.","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"797_CR186","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/j.1365-2141.2010.08191.x","volume":"149","author":"J Alamelu","year":"2010","unstructured":"Alamelu J, Liesner R. Modern management of severe platelet function disorders. Br J Haematol. 2010;149(6):813\u201323.","journal-title":"Br J Haematol"},{"issue":"10","key":"797_CR187","volume":"12","author":"G Mohan","year":"2020","unstructured":"Mohan G, Malayala SV, Mehta P, Balla M. A comprehensive review of congenital platelet disorders, thrombocytopenias and thrombocytopathies. Cureus. 2020;12(10):e11275.","journal-title":"Cureus"},{"key":"797_CR188","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.589812","volume":"8","author":"M Minkov","year":"2020","unstructured":"Minkov M, Zeitlhofer P, Zoubek A, Kager L, Panzer S, Haas OA. Novel compound heterozygous mutations in two families with Bernard-Soulier syndrome. Front Pediatr. 2020;8:589812.","journal-title":"Front Pediatr"},{"issue":"1","key":"797_CR189","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3109\/08880019709030883","volume":"14","author":"RJ Cohn","year":"1997","unstructured":"Cohn RJ, Sherman GG, Glencross DK. Flow cytometric analysis of platelet surface glycoproteins in the diagnosis of Bernard-Soulier syndrome. Pediatr Hematol Oncol. 1997;14(1):43\u201350.","journal-title":"Pediatr Hematol Oncol"},{"key":"797_CR190","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020885","author":"M Skaln\u00edkov\u00e1","year":"2022","unstructured":"Skaln\u00edkov\u00e1 M, Sta\u0148o Kozub\u00edk K, Trizuljak J, Vrzalov\u00e1 Z, Radov\u00e1 L, R\u00e9blov\u00e1 K, et al. A GP1BA variant in a Czech family with monoallelic Bernard-Soulier syndrome. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23020885.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"797_CR191","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000500797","volume":"143","author":"X Li","year":"2020","unstructured":"Li X, Wang S, Wu J, Wang H, Wang J, Dong X, et al. A case of Bernard-Soulier syndrome due to a novel homozygous missense mutation in an exon of the GP1BA gene. Acta Haematol. 2020;143(1):60\u20134.","journal-title":"Acta Haematol"},{"issue":"7","key":"797_CR192","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.3324\/haematol.2021.278893","volume":"107","author":"Q Lin","year":"2022","unstructured":"Lin Q, Zhou R, Meng P, Wu L, Yang L, Liu W, et al. Establishment of a Bernard-Soulier syndrome model in zebrafish. Haematologica. 2022;107(7):1655\u201368.","journal-title":"Haematologica"},{"issue":"1","key":"797_CR193","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3324\/haematol.2017.171132","volume":"103","author":"JM Bastida","year":"2018","unstructured":"Bastida JM, Lozano ML, Benito R, Janusz K, Palma-Barqueros V, Del Rey M, et al. Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders. Haematologica. 2018;103(1):148\u201362.","journal-title":"Haematologica"},{"key":"797_CR194","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910190","volume":"22","author":"S Barozzi","year":"2021","unstructured":"Barozzi S, Bozzi V, De Rocco D, Giangregorio T, Noris P, Savoia A, et al. A novel mutation in GP1BB reveals the role of the cytoplasmic domain of GPIb\u03b2 in the pathophysiology of Bernard-Soulier syndrome and GPIb-IX complex assembly. Int J Mol Sci. 2021;22:19.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"797_CR195","doi-asserted-by":"publisher","first-page":"705","DOI":"10.12669\/pjms.35.3.980","volume":"35","author":"S Farhan","year":"2019","unstructured":"Farhan S, Iqbal I, Ahmed N. Bernard Soulier syndrome: 10 years\u2019 experience at a tertiary care hospital. Pak J Med Sci. 2019;35(3):705\u20138.","journal-title":"Pak J Med Sci"},{"issue":"3","key":"797_CR196","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000107926","volume":"118","author":"N Da\u011fistan","year":"2007","unstructured":"Da\u011fistan N, Kunishima S. First Turkish case of Bernard-Soulier syndrome associated with GPIX N45S. Acta Haematol. 2007;118(3):146\u20138.","journal-title":"Acta Haematol"},{"issue":"1","key":"797_CR197","first-page":"105","volume":"11","author":"N Reisi","year":"2020","unstructured":"Reisi N. Bernard-Soulier syndrome or idiopathic thrombocytopenic purpura: A case series. Casp J Intern Med. 2020;11(1):105\u20139.","journal-title":"Casp J Intern Med"},{"issue":"1","key":"797_CR198","first-page":"3","volume":"7","author":"T Gh","year":"2014","unstructured":"Gh T. Quantitative immunophemotyping of platelet surface glycoproteins among Iranian patients with Bernard-Soulier syndrome. Iran J Blood Cancer. 2014;7(1):3\u20139.","journal-title":"Iran J Blood Cancer"},{"key":"797_CR199","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1080\/09537100701191323","volume":"18","author":"A Afrasiabi","year":"2007","unstructured":"Afrasiabi A, Lecchi A, Artoni A, Karimi M, Ashouri E, Peyvandi F, et al. Genetic characterization of patients with Bernard-Soulier syndrome and their relatives from Southern Iran. Platelets. 2007;18:409\u201313.","journal-title":"Platelets"},{"issue":"8","key":"797_CR200","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1111\/j.1538-7836.2011.04417.x","volume":"9","author":"E Sumitha","year":"2011","unstructured":"Sumitha E, Jayandharan GR, David S, Jacob RR, Sankari Devi G, Bargavi B, et al. Molecular basis of Bernard-Soulier syndrome in 27 patients from India. J Thromb Haemost. 2011;9(8):1590\u20138.","journal-title":"J Thromb Haemost"},{"issue":"7","key":"797_CR201","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3109\/09537104.2012.748186","volume":"24","author":"S Ali","year":"2013","unstructured":"Ali S, Ghosh K, Shetty S. Molecular pathology of Bernard-Soulier syndrome in Indian patients. Platelets. 2013;24(7):571\u20133.","journal-title":"Platelets"},{"key":"797_CR202","first-page":"89","volume-title":"Consults in obstetric anesthesiology","author":"S Orbach-Zinger","year":"2018","unstructured":"Orbach-Zinger S, Davis A, Ioscovich A. Bernard\u2013Soulier syndrome. In: Mankowitz SKW, editor. Consults in obstetric anesthesiology. Cham: Springer International Publishing; 2018. pp. 89\u201391."},{"issue":"3","key":"797_CR203","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1365-2257.2006.00780.x","volume":"28","author":"P Prabu","year":"2006","unstructured":"Prabu P, Parapia LA. Bernard-soulier syndrome in pregnancy. Clin Lab Haematol. 2006;28(3):198\u2013201.","journal-title":"Clin Lab Haematol"},{"issue":"1","key":"797_CR204","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1055\/s-0037-1612582","volume":"95","author":"C Rieger","year":"2006","unstructured":"Rieger C, Rank A, Fiegl M, Tischer J, Schiel X, Ostermann H, et al. Allogeneic stem cell transplantation as a new treatment option for patients with severe Bernard-Soulier syndrome. Thromb Haemost. 2006;95(1):190\u20131.","journal-title":"Thromb Haemost"},{"issue":"8","key":"797_CR205","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1080\/09537104.2017.1361526","volume":"28","author":"M Othman","year":"2017","unstructured":"Othman M, Emsley J. Gene of the issue: GP1BA gene mutations associated with bleeding. Platelets. 2017;28(8):832\u20136.","journal-title":"Platelets"},{"issue":"8","key":"797_CR206","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1055\/s-2007-1000368","volume":"33","author":"M Othman","year":"2007","unstructured":"Othman M. Platelet-type von Willebrand disease and type 2B von Willebrand disease: a story of nonidentical twins when two different genetic abnormalities evolve into similar phenotypes. Semin Thromb Hemost. 2007;33(8):780\u20136.","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"797_CR207","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.blre.2011.03.003","volume":"25","author":"M Othman","year":"2011","unstructured":"Othman M. Platelet-type von Willebrand disease: three decades in the life of a rare bleeding disorder. Blood Rev. 2011;25(4):147\u201353.","journal-title":"Blood Rev"},{"issue":"6","key":"797_CR208","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/j.1365-2141.2006.06078.x","volume":"133","author":"MS Enayat","year":"2006","unstructured":"Enayat MS, Guilliatt AM, Lester W, Wilde JT, Williams MD, Hill FG. Distinguishing between type 2B and pseudo-von Willebrand disease and its clinical importance. Br J Haematol. 2006;133(6):664\u20136.","journal-title":"Br J Haematol"},{"issue":"3","key":"797_CR209","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1160\/TH10-08-0523","volume":"105","author":"A Hamilton","year":"2011","unstructured":"Hamilton A, Ozelo M, Leggo J, Notley C, Brown H, Frontroth JP, et al. Frequency of platelet type versus type 2B von Willebrand disease. An international registry-based study. Thromb Haemost. 2011;105(3):501\u20138.","journal-title":"Thromb Haemost"},{"issue":"8","key":"797_CR210","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1177\/1076029614543825","volume":"20","author":"H Kaur","year":"2014","unstructured":"Kaur H, Ozelo M, Scovil S, James PD, Othman M. Systematic analysis of bleeding phenotype in PT-VWD compared to type 2B VWD using an electronic bleeding questionnaire. Clin Appl Thromb Hemost. 2014;20(8):765\u201371.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"2","key":"797_CR211","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/bjh.17174","volume":"192","author":"A Khoreva","year":"2021","unstructured":"Khoreva A, Abramova I, Deripapa E, Rodina Y, Roppelt A, Pershin D, et al. Efficacy of romiplostim in treatment of thrombocytopenia in children with Wiskott-aldrich syndrome. Br J Haematol. 2021;192(2):366\u201374.","journal-title":"Br J Haematol"},{"issue":"06","key":"797_CR212","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1055\/s-0038-1650385","volume":"75","author":"JL Miller","year":"1996","unstructured":"Miller JL. Platelet-type von Willebrand disease. Thromb Haemost. 1996;75(06):865\u20139.","journal-title":"Thromb Haemost"},{"key":"797_CR213","doi-asserted-by":"crossref","unstructured":"Othman M, Kaur H, Emsley J. Platelet-type von Willebrand disease: new insights into the molecular pathophysiology of a unique platelet defect. Semin Thromb Hemost. 2013;39(6):663-73.","DOI":"10.1055\/s-0033-1353442"},{"issue":"2","key":"797_CR214","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/jth.13204","volume":"14","author":"M Othman","year":"2016","unstructured":"Othman M, Kaur H, Favaloro EJ, Lillicrap D, Di Paola J, Harrison P, et al. Platelet type von Willebrand disease and registry report: communication from the SSC of the ISTH. J Thromb Haemost. 2016;14(2):411\u20134.","journal-title":"J Thromb Haemost"},{"key":"797_CR215","first-page":"94","volume":"473","author":"JP Frontroth","year":"2017","unstructured":"Frontroth JP, Favaloro EJ. Ristocetin-induced platelet aggregation (RIPA) and RIPA mixing studies. Hemost Thrombosis: Methods Protocols. 2017;473:94.","journal-title":"Hemost Thrombosis: Methods Protocols"},{"issue":"6","key":"797_CR216","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3324\/haematol.2009.015990","volume":"95","author":"S Giannini","year":"2010","unstructured":"Giannini S, Cecchetti L, Mezzasoma AM, Gresele P. Diagnosis of platelet-type von Willebrand disease by flow cytometry. Haematologica. 2010;95(6):1021.","journal-title":"Haematologica"},{"issue":"11","key":"797_CR217","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.1073\/pnas.88.11.4761","volume":"88","author":"JL Miller","year":"1991","unstructured":"Miller JL, Cunningham D, Lyle VA, Finch CN. Mutation in the gene encoding the alpha chain of platelet glycoprotein Ib in platelet-type von Willebrand disease. Proc Natl Acad Sci U S A. 1991;88(11):4761\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"797_CR218","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1160\/TH12-04-0189","volume":"108","author":"S Enayat","year":"2012","unstructured":"Enayat S, Ravanbod S, Rassoulzadegan M, Jazebi M, Tarighat S, Ala F, et al. A novel D235Y mutation in the GP1BA gene enhances platelet interaction with von Willebrand factor in an Iranian family with platelet-type von Willebrand disease. Thromb Haemost. 2012;108(11):946\u201354.","journal-title":"Thromb Haemost"},{"issue":"4","key":"797_CR219","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/bjh.19025","volume":"203","author":"C Monteiro","year":"2023","unstructured":"Monteiro C, Gon\u00e7alves A, Pereira M, Lau C, Morais S, Santos R. A new case of platelet-type von Willebrand disease supports the recent findings of gain\u2010of\u2010function GP1BA variants outside the C\u2010terminal disulphide loop enhances affinity for von Willebrand factor. Br J Haematol. 2023;203(4):673\u20137.","journal-title":"Br J Haematol"},{"issue":"7","key":"797_CR220","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1182\/bloodadvances.2021005463","volume":"6","author":"L Bury","year":"2022","unstructured":"Bury L, Falcinelli E, Kuchi Bhotla H, Mezzasoma AM, Guglielmini G, Tischer A, et al. A p. Arg127Gln variant in GPIb\u03b1 LRR5 allosterically enhances affinity for VWF: a novel form of platelet-type VWD. Blood Adv. 2022;6(7):2236\u201346.","journal-title":"Blood Adv"},{"key":"797_CR221","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.644671","author":"P Vel\u00e1zquez-D\u00edaz","year":"2021","unstructured":"Vel\u00e1zquez-D\u00edaz P, Nakajima E, Sorkhdini P, Hernandez-Gutierrez A, Eberle A, Yang D, et al. Hermansky-pudlak syndrome and lung disease: pathogenesis and therapeutics. Front Pharmacol. 2021. https:\/\/doi.org\/10.3389\/fphar.2021.644671.","journal-title":"Front Pharmacol"},{"issue":"3","key":"797_CR222","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/ng1196-300","volume":"14","author":"J Oh","year":"1996","unstructured":"Oh J, Bailin T, Fukai K, Feng GH, Ho L, Mao JI, et al. Positional cloning of a gene for Hermansky-Pudlak syndrome, a disorder of cytoplasmic organelles. Nat Genet. 1996;14(3):300\u20136.","journal-title":"Nat Genet"},{"issue":"1","key":"797_CR223","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S1097-2765(00)80170-7","volume":"3","author":"EC Dell\u2019Angelica","year":"1999","unstructured":"Dell\u2019Angelica EC, Shotelersuk V, Aguilar RC, Gahl WA, Bonifacino JS. Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the beta 3A subunit of the AP-3 adaptor. Mol Cell. 1999;3(1):11\u201321.","journal-title":"Mol Cell"},{"issue":"4","key":"797_CR224","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/ng576","volume":"28","author":"Y Anikster","year":"2001","unstructured":"Anikster Y, Huizing M, White J, Shevchenko YO, Fitzpatrick DL, Touchman JW, et al. Mutation of a new gene causes a unique form of Hermansky-pudlak syndrome in a genetic isolate of central Puerto Rico. Nat Genet. 2001;28(4):376\u201380.","journal-title":"Nat Genet"},{"issue":"3","key":"797_CR225","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/ng835","volume":"30","author":"T Suzuki","year":"2002","unstructured":"Suzuki T, Li W, Zhang Q, Karim A, Novak EK, Sviderskaya EV, et al. Hermansky-Pudlak syndrome is caused by mutations in HPS4, the human homolog of the mouse light-ear gene. Nat Genet. 2002;30(3):321\u20134.","journal-title":"Nat Genet"},{"issue":"2","key":"797_CR226","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/ng1087","volume":"33","author":"Q Zhang","year":"2003","unstructured":"Zhang Q, Zhao B, Li W, Oiso N, Novak EK, Rusiniak ME, et al. Ru2 and Ru encode mouse orthologs of the genes mutated in human Hermansky-Pudlak syndrome types 5 and 6. Nat Genet. 2003;33(2):145\u201353.","journal-title":"Nat Genet"},{"issue":"1","key":"797_CR227","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/ng1229","volume":"35","author":"W Li","year":"2003","unstructured":"Li W, Zhang Q, Oiso N, Novak EK, Gautam R, O\u2019Brien EP, et al. Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Nat Genet. 2003;35(1):84\u20139.","journal-title":"Nat Genet"},{"issue":"1","key":"797_CR228","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1086\/499338","volume":"78","author":"NV Morgan","year":"2006","unstructured":"Morgan NV, Pasha S, Johnson CA, Ainsworth JR, Eady RA, Dawood B, et al. A germline mutation in BLOC1S3\/reduced pigmentation causes a novel variant of Hermansky-Pudlak syndrome (HPS8). Am J Hum Genet. 2006;78(1):160\u20136.","journal-title":"Am J Hum Genet"},{"issue":"13","key":"797_CR229","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1182\/blood-2012-01-404350","volume":"119","author":"R Badolato","year":"2012","unstructured":"Badolato R, Prandini A, Caracciolo S, Colombo F, Tabellini G, Giacomelli M, et al. Exome sequencing reveals a pallidin mutation in a Hermansky-Pudlak\u2013like primary immunodeficiency syndrome. Blood. 2012;119(13):3185\u20137.","journal-title":"Blood"},{"issue":"8","key":"797_CR230","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1182\/blood-2015-09-671636","volume":"127","author":"S Ammann","year":"2016","unstructured":"Ammann S, Schulz A, Kr\u00e4geloh-Mann I, Dieckmann NMG, Niethammer K, Fuchs S, et al. Mutations in AP3D1 associated with immunodeficiency and seizures define a new type of Hermansky-Pudlak syndrome. Blood. 2016;127(8):997\u20131006.","journal-title":"Blood"},{"issue":"10","key":"797_CR231","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1038\/s41436-020-0867-5","volume":"22","author":"P Pennamen","year":"2020","unstructured":"Pennamen P, Le L, Tingaud-Sequeira A, Fiore M, Bauters A, Van Duong B\u00e9atrice N, et al. BLOC1S5 pathogenic variants cause a new type of Hermansky-Pudlak syndrome. Genet Med. 2020;22(10):1613\u201322.","journal-title":"Genet Med"},{"issue":"10","key":"797_CR232","first-page":"1839","volume":"13","author":"GW Vicary","year":"2016","unstructured":"Vicary GW, Vergne Y, Santiago-Cornier A, Young LR, Roman J. Pulmonary fibrosis in Hermansky-Pudlak syndrome. Ann Am Thorac Soc. 2016;13(10):1839\u201346.","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"797_CR233","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1203\/00006450-200202000-00006","volume":"51","author":"M Huizing","year":"2002","unstructured":"Huizing M, Scher CD, Strovel E, Fitzpatrick DL, Hartnell LM, Anikster Y, et al. Nonsense mutations in ADTB3A cause complete deficiency of the \u03b23A subunit of adaptor complex-3 and severe Hermansky-Pudlak syndrome type 2. Pediatr Res. 2002;51(2):150\u20138.","journal-title":"Pediatr Res"},{"key":"797_CR234","unstructured":"Introne WJHM, Malicdan MCV, Hermansky-Pudlak S et al. 2000 Jul 24 [Updated 2023 May 25] Seattle (WA): University of Washington, Seattle1993-2024. Available from:\u00a0https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1287\/."},{"issue":"4","key":"797_CR235","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/ajh.2830260403","volume":"26","author":"CJ Witkop","year":"1987","unstructured":"Witkop CJ, Krumwiede M, Sedano H, White JG. Reliability of absent platelet dense bodies as a diagnostic criterion for Hermansky-Pudlak syndrome. Am J Hematol. 1987;26(4):305\u201311.","journal-title":"Am J Hematol"},{"issue":"1","key":"797_CR236","first-page":"57","volume":"68","author":"JG White","year":"1972","unstructured":"White JG, Witkop CJ. Effects of normal and aspirin platelets on defective secondary aggregation in the Hermansky-Pudlak syndrome. A test for storage pool deficient platelets. Am J Pathol. 1972;68(1):57\u201366.","journal-title":"Am J Pathol"},{"issue":"9","key":"797_CR237","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1111\/jth.15484","volume":"19","author":"J Perez Botero","year":"2021","unstructured":"Perez Botero J, Di Paola J. Diagnostic approach to the patient with a suspected inherited platelet disorder: who and how to test. J Thromb Haemost. 2021;19(9):2127\u201336.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"797_CR238","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1365-2141.1995.tb03315.x","volume":"89","author":"JE Wall","year":"1995","unstructured":"Wall JE, Buijs-Wilts M, Arnold JT, Wang W, White MM, Jennings LK, et al. A flow cytometric assay using mepacrine for study of uptake and release of platelet dense granule contents. Br J Haematol. 1995;89(2):380\u20135.","journal-title":"Br J Haematol"},{"issue":"4","key":"797_CR239","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1309\/3KRYCPNAPDTVFWGY","volume":"127","author":"E Maurer-Spurej","year":"2007","unstructured":"Maurer-Spurej E, Pittendreigh C, Wu JK. Diagnosing platelet delta-storage pool disease in children by flow cytometry. Am J Clin Pathol. 2007;127(4):626\u201332.","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"797_CR240","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/jth.13269","volume":"14","author":"D Westmoreland","year":"2016","unstructured":"Westmoreland D, Shaw M, Grimes W, Metcalf DJ, Burden JJ, Gomez K, et al. Super-resolution microscopy as a potential approach to diagnosis of platelet granule disorders. J Thromb Haemost. 2016;14(4):839\u201349.","journal-title":"J Thromb Haemost"},{"issue":"3","key":"797_CR241","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/humu.23968","volume":"41","author":"M Huizing","year":"2020","unstructured":"Huizing M, Malicdan MCV, Wang JA, Pri-Chen H, Hess RA, Fischer R, et al. Hermansky-pudlak syndrome: mutation update. Hum Mutat. 2020;41(3):543\u201380.","journal-title":"Hum Mutat"},{"issue":"1","key":"797_CR242","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1182\/hematology.2020000091","volume":"2020","author":"MP Lambert","year":"2020","unstructured":"Lambert MP. Improving interpretation of genetic testing for hereditary hemorrhagic, thrombotic, and platelet disorders. Hematology. 2020;2020(1):76\u201381.","journal-title":"Hematology"},{"key":"797_CR243","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.945175","volume":"26","author":"LA Alhomayin","year":"2025","unstructured":"Alhomayin LA, Alharbi AR, Nadama AR, Cal JH, Paramasivam M. Hermansky-pudlak syndrome type 1 presenting with interstitial lung disease: a report of a rare case from Saudi Arabia. Am J Case Rep. 2025;26:e945175.","journal-title":"Am J Case Rep"},{"issue":"3","key":"797_CR244","doi-asserted-by":"publisher","first-page":"e389","DOI":"10.1097\/MPH.0000000000002552","volume":"45","author":"HF Nazir","year":"2023","unstructured":"Nazir HF, Sukaiti NA, Khater D, Elbeshlawy I, Hassanein N. Hermansky-pudlak syndrome: spectrum in Oman. J Pediatr Hematol Oncol. 2023;45(3):e389-94.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"797_CR245","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1159\/000091609","volume":"73","author":"DM Pierson","year":"2006","unstructured":"Pierson DM, Ionescu D, Qing G, Yonan AM, Parkinson K, Colby TC, et al. Pulmonary fibrosis in hermansky-pudlak syndrome. A case report and review. Respiration. 2006;73(3):382\u201395.","journal-title":"Respiration"},{"key":"797_CR246","unstructured":"Introne WJ, Huizing M, Malicdan MCV, O'Brien KJ, Gahl WA. Hermansky-Pudlak Syndrome. 2000 Jul 24 [updated 2023 May 25]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132025."},{"issue":"1","key":"797_CR247","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1542\/peds.2012-4003","volume":"132","author":"SL Seward Jr","year":"2013","unstructured":"Seward SL Jr, Gahl WA. Hermansky-pudlak syndrome: health care throughout life. Pediatrics. 2013;132(1):153\u201360.","journal-title":"Pediatrics"},{"issue":"2","key":"797_CR248","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1006\/mgme.1999.2927","volume":"68","author":"W Introne","year":"1999","unstructured":"Introne W, Boissy RE, Gahl WA. Clinical, molecular, and cell biological aspects of Chediak\u2013Higashi syndrome. Mol Genet Metab. 1999;68(2):283\u2013303.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"797_CR249","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.jaci.2015.08.039","volume":"137","author":"A Gil-Krzewska","year":"2016","unstructured":"Gil-Krzewska A, Wood SM, Murakami Y, Nguyen V, Chiang SCC, Cullinane AR, et al. Chediak-Higashi syndrome: lysosomal trafficking regulator domains regulate exocytosis of lytic granules but not cytokine secretion by natural killer cells. J Allergy Clin Immunol. 2016;137(4):1165\u201377.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"797_CR250","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1136\/jmg-2023-109420","volume":"61","author":"M Morimoto","year":"2024","unstructured":"Morimoto M, Nicoli ER, Kuptanon C, Roney JC, Serra-Vinardell J, Sharma P, et al. Spectrum of LYST mutations in Chediak-Higashi syndrome: a report of novel variants and a comprehensive review of the literature. J Med Genet. 2024;61(3):212\u201323.","journal-title":"J Med Genet"},{"issue":"4","key":"797_CR251","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1034\/j.1600-0749.2002.02038.x","volume":"15","author":"SL Shiflett","year":"2002","unstructured":"Shiflett SL, Kaplan J, Ward DM. Chediak\u2013Higashi syndrome: a rare disorder of lysosomes and lysosome related organelles. Pigment Cell Res. 2002;15(4):251\u20137.","journal-title":"Pigment Cell Res"},{"key":"797_CR252","unstructured":"Ajitkumar A, Yarrarapu SNS, Chediak-Higashi KR. Syndrome In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-: In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan-; Available from:https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK507881\/. Updated 24 Jul 2023."},{"key":"797_CR253","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e3282f2bcce","author":"J Kaplan","year":"2008","unstructured":"Kaplan J, De Domenico I, Ward DM. Chediak-Higashi syndrome. Curr Opin Hematol. 2008. https:\/\/doi.org\/10.1097\/MOH.0b013e3282f2bcce.","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"797_CR254","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ymgme.2005.02.011","volume":"85","author":"W Zarzour","year":"2005","unstructured":"Zarzour W, Kleta R, Frangoul H, Suwannarat P, Jeong A, Kim SY, et al. Two novel CHS1 (LYST) mutations: clinical correlations in an infant with Chediak-Higashi syndrome. Mol Genet Metab. 2005;85(2):125\u201332.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"797_CR255","doi-asserted-by":"publisher","first-page":"e248","DOI":"10.1097\/MPH.0000000000000025","volume":"36","author":"S Al-Tamemi","year":"2014","unstructured":"Al-Tamemi S, Al-Zadjali S, Al-Ghafri F, Dennison D. Chediak-Higashi syndrome: novel mutation of the CHS1\/LYST gene in 3 Omani patients. J Pediatr Hematol Oncol. 2014;36(4):e248-50.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"797_CR256","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-019-0765-3","volume":"20","author":"L Sheng","year":"2019","unstructured":"Sheng L, Zhang W, Gu J, Shen K, Luo H, Yang Y. Novel mutations of STXBP2 and LYST associated with adult haemophagocytic lymphohistiocytosis with Epstein-Barr virus infection: a case report. BMC Med Genet. 2019;20(1):34.","journal-title":"BMC Med Genet"},{"issue":"2","key":"797_CR257","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s12185-017-2223-3","volume":"106","author":"E Mukda","year":"2017","unstructured":"Mukda E, Trachoo O, Pasomsub E, Tiyasirichokchai R, Iemwimangsa N, Sosothikul D, et al. Exome sequencing for simultaneous mutation screening in children with hemophagocytic lymphohistiocytosis. Int J Hematol. 2017;106(2):282\u201390.","journal-title":"Int J Hematol"},{"issue":"6","key":"797_CR258","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1002\/ajmg.a.33389","volume":"152a","author":"I Manoli","year":"2010","unstructured":"Manoli I, Golas G, Westbroek W, Vilboux T, Markello TC, Introne W, et al. Chediak-Higashi syndrome with early developmental delay resulting from paternal heterodisomy of chromosome 1. Am J Med Genet A. 2010;152a(6):1474\u201383.","journal-title":"Am J Med Genet A"},{"issue":"6","key":"797_CR259","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/sj.ejhg.5200355","volume":"7","author":"R Dufourcq-Lagelouse","year":"1999","unstructured":"Dufourcq-Lagelouse R, Lambert N, Duval M, Viot G, Vilmer E, Fischer A, et al. Chediak-Higashi syndrome associated with maternal uniparental isodisomy of chromosome 1. Eur J Hum Genet. 1999;7(6):633\u20137.","journal-title":"Eur J Hum Genet"},{"key":"797_CR260","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-46","volume":"8","author":"JD Weisfeld-Adams","year":"2013","unstructured":"Weisfeld-Adams JD, Mehta L, Rucker JC, Dembitzer FR, Szporn A, Lublin FD, et al. Atypical Ch\u00e9diak-Higashi syndrome with attenuated phenotype: three adult siblings homozygous for a novel LYST deletion and with neurodegenerative disease. Orphanet J Rare Dis. 2013;8:46.","journal-title":"Orphanet J Rare Dis"},{"key":"797_CR261","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.625591","volume":"12","author":"M Boluda-Navarro","year":"2021","unstructured":"Boluda-Navarro M, Ib\u00e1\u00f1ez M, Liquori A, Franco-Jarava C, Mart\u00ednez-Gallo M, Rodr\u00edguez-Vega H, et al. Case report: partial uniparental disomy unmasks a novel recessive mutation in the LYST gene in a patient with a severe phenotype of Ch\u00e9diak-Higashi syndrome. Front Immunol. 2021;12:625591.","journal-title":"Front Immunol"},{"issue":"12","key":"797_CR262","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1002\/ajmg.a.61886","volume":"182","author":"DS Yarnell","year":"2020","unstructured":"Yarnell DS, Roney JC, Teixeira C, Freitas MI, Cipriano A, Leuschner P, et al. Diagnosis of Chediak Higashi disease in a 67-year old woman. Am J Med Genet A. 2020;182(12):3007\u201313.","journal-title":"Am J Med Genet A"},{"issue":"2","key":"797_CR263","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/15513815.2022.2077489","volume":"42","author":"M Safavi","year":"2023","unstructured":"Safavi M, Parvaneh N. Chediak Higashi syndrome with hemophagocytic lymphohistiocytosis. Fetal Pediatr Pathol. 2023;42(2):259\u201362.","journal-title":"Fetal Pediatr Pathol"},{"issue":"7","key":"797_CR264","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/01.mph.0000172280.27318.80","volume":"27","author":"N Rezaei","year":"2005","unstructured":"Rezaei N, Farhoudi A, Ramyar A, Pourpak Z, Aghamohammadi A, Mohammadpour B, et al. Congenital neutropenia and primary immunodeficiency disorders: a survey of 26 Iranian patients. J Pediatr Hematol Oncol. 2005;27(7):351\u20136.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"797_CR265","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1600-0897.2006.00409.x","volume":"56","author":"N Rezaei","year":"2006","unstructured":"Rezaei N, Pourpak Z, Aghamohammadi A, Farhoudi A, Movahedi M, Gharagozlou M, et al. Consanguinity in primary immunodeficiency disorders; the report from Iranian primary immunodeficiency registry. Am J Reprod Immunol. 2006;56(2):145\u201351.","journal-title":"Am J Reprod Immunol"},{"key":"797_CR266","volume":"2021","author":"K Shimizu","year":"2021","unstructured":"Shimizu K, Hayashi M, Ito N, Hamada K, Koizumi G, Kurohara K, et al. Oral management of a haematopoietic stem cell transplant recipient with Ch\u00e9diak-Higashi syndrome. Case Rep Dent. 2021;2021:9918199.","journal-title":"Case Rep Dent"},{"issue":"2","key":"797_CR267","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124\u201331.","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"797_CR268","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/ng.884","volume":"43","author":"WH Kahr","year":"2011","unstructured":"Kahr WH, Hinckley J, Li L, Schwertz H, Christensen H, Rowley JW, et al. Mutations in NBEAL2, encoding a BEACH protein, cause Gray platelet syndrome. Nat Genet. 2011;43(8):738\u201340.","journal-title":"Nat Genet"},{"issue":"8","key":"797_CR269","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1182\/blood-2006-02-004101","volume":"109","author":"VN Tubman","year":"2007","unstructured":"Tubman VN, Levine JE, Campagna DR, Monahan-Earley R, Dvorak AM, Neufeld EJ, et al. X-linked Gray platelet syndrome due to a GATA1 Arg216Gln mutation. Blood. 2007;109(8):3297\u20139.","journal-title":"Blood"},{"issue":"3","key":"797_CR270","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1056\/NEJMoa1308130","volume":"370","author":"D Monteferrario","year":"2014","unstructured":"Monteferrario D, Bolar NA, Marneth AE, Hebeda KM, Bergevoet SM, Veenstra H, et al. A dominant-negative GFI1B mutation in the Gray platelet syndrome. N Engl J Med. 2014;370(3):245\u201353.","journal-title":"N Engl J Med"},{"issue":"6","key":"797_CR271","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1080\/09537104.2018.1478405","volume":"29","author":"FG Pluthero","year":"2018","unstructured":"Pluthero FG, Di Paola J, Carcao MD, Kahr WHA. NBEAL2 mutations and bleeding in patients with Gray platelet syndrome. Platelets. 2018;29(6):632\u20135.","journal-title":"Platelets"},{"issue":"4","key":"797_CR272","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3324\/haematol.2016.152777","volume":"102","author":"A Wijgaerts","year":"2017","unstructured":"Wijgaerts A, Wittevrongel C, Thys C, Devos T, Peerlinck K, Tijssen MR, et al. The transcription factor GATA1 regulates NBEAL2 expression through a long-distance enhancer. Haematologica. 2017;102(4):695\u2013706.","journal-title":"Haematologica"},{"issue":"6","key":"797_CR273","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/0002-9343(71)90311-1","volume":"51","author":"G Raccuglia","year":"1971","unstructured":"Raccuglia G. Gray platelet syndrome. A variety of qualitative platelet disorder. Am J Med. 1971;51(6):818\u201328.","journal-title":"Am J Med"},{"key":"797_CR274","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2147\/JBM.S270018","volume":"12","author":"AC Glembotsky","year":"2021","unstructured":"Glembotsky AC, De Luca G, Heller PG. A deep dive into the pathology of Gray platelet syndrome: new insights on immune dysregulation. J Blood Med. 2021;12:719\u201332.","journal-title":"J Blood Med"},{"issue":"2","key":"797_CR275","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29916","volume":"70","author":"R Tyagi","year":"2023","unstructured":"Tyagi R, Basu S, Kumar A, Saikia UN, Siniah S, Sharma S, et al. Thrombocytopenia in a child with polyarthritis: a pointer to Gray platelet syndrome. Pediatr Blood Cancer. 2023;70(2):e29916.","journal-title":"Pediatr Blood Cancer"},{"key":"797_CR276","doi-asserted-by":"crossref","unstructured":"Bain, B.J. (2023). Gray platelet syndrome. In Hematology, B.J. Bain (Ed.).ch51","DOI":"10.1002\/9781394179756"},{"issue":"1","key":"797_CR277","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.blre.2005.12.003","volume":"21","author":"AT Nurden","year":"2007","unstructured":"Nurden AT, Nurden P. The gray platelet syndrome: clinical spectrum of the disease. Blood Rev. 2007;21(1):21\u201336.","journal-title":"Blood Rev"},{"key":"797_CR278","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/978-3-031-43156-2_17","volume-title":"Congenital bleeding disorders: diagnosis and management","author":"F Kianinodeh","year":"2023","unstructured":"Kianinodeh F, Hosseini MS, Bain BJ. Gray platelet syndrome: diagnosis and management. In: Dorgalaleh A, editor. Congenital bleeding disorders: diagnosis and management. Cham: Springer International Publishing; 2023. pp. 445\u201363."},{"key":"797_CR279","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9082636","author":"J Le Blanc","year":"2020","unstructured":"Le Blanc J, Mullier F, Vayne C, Lordkipanidz\u00e9 M. Advances in platelet function testing\u2014light transmission aggregometry and beyond. J Clin Med. 2020. https:\/\/doi.org\/10.3390\/jcm9082636.","journal-title":"J Clin Med"},{"issue":"2","key":"797_CR280","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/ajcp\/aqaa229","volume":"156","author":"H Tariq","year":"2021","unstructured":"Tariq H, Perez Botero J, Higgins RA, Medina EA. Gray platelet syndrome presenting with pancytopenia, splenomegaly, and bone marrow fibrosis. Am J Clin Pathol. 2021;156(2):253\u20138.","journal-title":"Am J Clin Pathol"},{"key":"797_CR281","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/978-3-319-76723-9_16","volume-title":"Congenital bleeding disorders: diagnosis and management","author":"H Shahraki","year":"2018","unstructured":"Shahraki H, Dorgalaleh A, Bain BJ. Gray platelet syndrome (GPS). In: Dorgalaleh A, editor. Congenital bleeding disorders: diagnosis and management. Cham: Springer International Publishing; 2018. pp. 379\u201396."},{"issue":"1","key":"797_CR282","doi-asserted-by":"publisher","DOI":"10.1080\/09537104.2022.2157808","volume":"34","author":"FG Pluthero","year":"2023","unstructured":"Pluthero FG, Kahr WHA. Evaluation of human platelet granules by structured illumination laser fluorescence microscopy. Platelets. 2023;34(1):2157808.","journal-title":"Platelets"},{"issue":"8","key":"797_CR283","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3109\/09537104.2014.994093","volume":"26","author":"LM Larocca","year":"2015","unstructured":"Larocca LM, Heller PG, Podda G, Pujol-Moix N, Glembotsky AC, Pecci A, et al. Megakaryocytic emperipolesis and platelet function abnormalities in five patients with Gray platelet syndrome. Platelets. 2015;26(8):751\u20137.","journal-title":"Platelets"},{"issue":"17","key":"797_CR284","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1182\/blood.2019004776","volume":"136","author":"MC Sims","year":"2020","unstructured":"Sims MC, Mayer L, Collins JH, Bariana TK, Megy K, Lavenu-Bombled C, et al. Novel manifestations of immune dysregulation and granule defects in Gray platelet syndrome. Blood. 2020;136(17):1956\u201367.","journal-title":"Blood"},{"issue":"23","key":"797_CR285","doi-asserted-by":"publisher","first-page":"4990","DOI":"10.1182\/blood-2010-05-286534","volume":"116","author":"M Gunay-Aygun","year":"2010","unstructured":"Gunay-Aygun M, Zivony-Elboum Y, Gumruk F, Geiger D, Cetin M, Khayat M, et al. Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p. Blood. 2010;116(23):4990\u20135001.","journal-title":"Blood"},{"issue":"12","key":"797_CR286","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1182\/blood-2010-12-322990","volume":"117","author":"S Fabbro","year":"2011","unstructured":"Fabbro S, Kahr WH, Hinckley J, Wang K, Moseley J, Ryu GY, et al. Homozygosity mapping with SNP arrays confirms 3p21 as a recessive locus for Gray platelet syndrome and narrows the interval significantly. Blood. 2011;117(12):3430\u20134.","journal-title":"Blood"},{"issue":"4","key":"797_CR287","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1007\/s12288-022-01531-3","volume":"38","author":"A Mevalegire Venkatagiri","year":"2022","unstructured":"Mevalegire Venkatagiri A, Vijayasekharan K, Bhat KV, Koulmane Laxminarayana SL, Belurkar S, Godkhindi VM. Gray platelet syndrome with severe thrombocytopenia: a novel NBEAL2 gene variant from India. Indian J Hematol Blood Transfus. 2022;38(4):754\u20136.","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"11","key":"797_CR288","first-page":"e48359","volume":"15","author":"BG Alasmari","year":"2023","unstructured":"Alasmari BG, Rayees S, Althubaiti S, Elzubair L, Chendeb S. Gray platelet syndrome in a neonate with VACTERL association: A novel homozygous pathogenic variant c.5257C\u2009>\u2009T in the NBEAL2 gene. Cureus. 2023;15(11):e48359.","journal-title":"Cureus"},{"key":"797_CR289","doi-asserted-by":"publisher","DOI":"10.1177\/23247096231196697","volume":"11","author":"DI Barghouthi","year":"2023","unstructured":"Barghouthi DI, Abu-Hilal LH, Njoum Y, Hasan AD, Alshawwa K, Hourani F. Gray platelet syndrome-unusual presentation with spontaneous splenic rupture: a case report and literature review. J Invest Med High Impact Case Rep. 2023;11:23247096231196697.","journal-title":"J Invest Med High Impact Case Rep"},{"issue":"4","key":"797_CR290","first-page":"269","volume":"91","author":"AM Ardila-Chevel","year":"2023","unstructured":"Ardila-Chevel AM, Rodr\u00edguez-V\u00e1squez C, V\u00e9lez-Cuervo SM. Grey platelet syndrome and pregnancy: case report and literature review. Ginecol Obstet Mex. 2023;91(4):269\u201373.","journal-title":"Ginecol Obstet Mex"},{"issue":"3","key":"797_CR291","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1080\/09537104.2017.1306041","volume":"29","author":"L Cao","year":"2018","unstructured":"Cao L, Su J, Li J, Yu Z, Bai X, Wang Z, et al. A novel nonsense NBEAL2 gene mutation causing severe bleeding in a patient with Gray platelet syndrome. Platelets. 2018;29(3):288\u201391.","journal-title":"Platelets"},{"issue":"4","key":"797_CR292","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1055\/s-0038-1646056","volume":"58","author":"SL Pfueller","year":"1987","unstructured":"Pfueller SL, Howard MA, White JG, Menon C, Berry EW. Shortening of bleeding time by 1-deamino-8-arginine vasopressin (DDAVP) in the absence of platelet von Willebrand factor in Gray platelet syndrome. Thromb Haemost. 1987;58(4):1060\u20133.","journal-title":"Thromb Haemost"},{"issue":"4","key":"797_CR293","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1080\/09537104.2019.1663809","volume":"31","author":"R Favier","year":"2020","unstructured":"Favier R, Roussel X, Audia S, Bordet JC, De Maistre E, Hirsch P, et al. Correction of severe myelofibrosis, impaired platelet functions and abnormalities in a patient with gray platelet syndrome successfully treated by stem cell transplantation. Platelets. 2020;31(4):536\u201340.","journal-title":"Platelets"},{"issue":"7","key":"797_CR294","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1080\/09537100701280670","volume":"18","author":"JG White","year":"2007","unstructured":"White JG. Platelet storage pool deficiency in Jacobsen syndrome. Platelets. 2007;18(7):522\u20137.","journal-title":"Platelets"},{"issue":"8","key":"797_CR295","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/jhg.2010.51","volume":"55","author":"T Ji","year":"2010","unstructured":"Ji T, Wu Y, Wang H, Wang J, Jiang Y. Diagnosis and fine mapping of a deletion in distal 11q in two Chinese patients with developmental delay. J Hum Genet. 2010;55(8):486\u20139.","journal-title":"J Hum Genet"},{"issue":"1","key":"797_CR296","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1172\/JCI21197","volume":"114","author":"H Raslova","year":"2004","unstructured":"Raslova H, Komura E, Le Cou\u00e9dic JP, Larbret F, Debili N, Feunteun J, et al. FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau\/Jacobsen thrombopenia. J Clin Invest. 2004;114(1):77\u201384.","journal-title":"J Clin Invest"},{"issue":"25","key":"797_CR297","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1038\/sj.onc.1201502","volume":"15","author":"JL Schwachtgen","year":"1997","unstructured":"Schwachtgen JL, Janel N, Barek L, Duterque-Coquillaud M, Ghysdael J, Meyer D, et al. Ets transcription factors bind and transactivate the core promoter of the von Willebrand factor gene. Oncogene. 1997;15(25):3091\u2013102.","journal-title":"Oncogene"},{"issue":"2","key":"797_CR298","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1074-7613(00)00017-0","volume":"13","author":"A Hart","year":"2000","unstructured":"Hart A, Melet F, Grossfeld P, Chien K, Jones C, Tunnacliffe A, et al. Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity. 2000;13(2):167\u201377.","journal-title":"Immunity"},{"issue":"7","key":"797_CR299","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s10875-022-01303-8","volume":"42","author":"EJ Huisman","year":"2022","unstructured":"Huisman EJ, Brooimans AR, Mayer S, Joosten M, de Bont L, Dekker M, et al. Patients with chromosome 11q deletions are characterized by inborn errors of immunity involving both B and T lymphocytes. J Clin Immunol. 2022;42(7):1521\u201334.","journal-title":"J Clin Immunol"},{"issue":"6","key":"797_CR300","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/ajmg.a.61113","volume":"179","author":"S Conrad","year":"2019","unstructured":"Conrad S, Demurger F, Moradkhani K, Pichon O, Le Caignec C, Pascal C, et al. 11q24.2q24.3 microdeletion in two families presenting features of Jacobsen syndrome, without intellectual disability: role of FLI1, ETS1, and SENCR long noncoding RNA. Am J Med Genet A. 2019;179(6):993\u20131000.","journal-title":"Am J Med Genet A"},{"issue":"3","key":"797_CR301","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/ajmg.c.31448","volume":"169","author":"R Favier","year":"2015","unstructured":"Favier R, Akshoomoff N, Mattson S, Grossfeld P. Jacobsen syndrome: advances in our knowledge of phenotype and genotype. Am J Med Genet C Semin Med Genet. 2015;169(3):239\u201350.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"2","key":"797_CR302","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1055\/s-0029-1220329","volume":"35","author":"S Clauser","year":"2009","unstructured":"Clauser S, Cramer-Bord\u00e9 E. Role of platelet electron microscopy in the diagnosis of platelet disorders. Semin Thromb Hemost. 2009;35(2):213\u201323.","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"797_CR303","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-017-1535-5","volume":"12","author":"Y Ichimiya","year":"2018","unstructured":"Ichimiya Y, Wada Y, Kunishima S, Tsukamoto K, Kosaki R, Sago H, et al. 11q23 deletion syndrome (Jacobsen syndrome) with severe bleeding: a case report. J Med Case Rep. 2018;12(1):3.","journal-title":"J Med Case Rep"},{"issue":"5","key":"797_CR304","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1160\/TH03-02-0120","volume":"90","author":"R Favier","year":"2003","unstructured":"Favier R, Jondeau K, Boutard P, Grossfeld P, Reinert P, Jones C, et al. Paris-Trousseau syndrome: clinical, hematological, molecular data of ten new cases. Thromb Haemost. 2003;90(5):893\u20137.","journal-title":"Thromb Haemost"},{"key":"797_CR305","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8166-1-23","volume":"1","author":"C Tyson","year":"2008","unstructured":"Tyson C, Qiao Y, Harvard C, Liu X, Bernier FP, McGillivray B, et al. Submicroscopic deletions of 11q24-25 in individuals without Jacobsen syndrome: re-examination of the critical region by high-resolution array-CGH. Mol Cytogenet. 2008;1:23.","journal-title":"Mol Cytogenet"},{"issue":"10","key":"797_CR306","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1002\/ajmg.a.35537","volume":"158a","author":"M Trkova","year":"2012","unstructured":"Trkova M, Becvarova V, Hynek M, Hnykova L, Hlavova E, Kreckova G, et al. SNP array and phenotype correlation shows that FLI1 deletion per se is not responsible for thrombocytopenia development in Jacobsen syndrome. Am J Med Genet A. 2012;158a(10):2545\u201350.","journal-title":"Am J Med Genet A"},{"issue":"17","key":"797_CR307","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1182\/blood-2015-06-650887","volume":"126","author":"WS Stevenson","year":"2015","unstructured":"Stevenson WS, Rabbolini DJ, Beutler L, Chen Q, Gabrielli S, Mackay JP, et al. Paris-trousseau thrombocytopenia is phenocopied by the autosomal recessive inheritance of a DNA-binding domain mutation in FLI1. Blood. 2015;126(17):2027\u201330.","journal-title":"Blood"},{"issue":"25","key":"797_CR308","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.1182\/blood-2013-06-506873","volume":"122","author":"J Stockley","year":"2013","unstructured":"Stockley J, Morgan NV, Bem D, Lowe GC, Lordkipanidz\u00e9 M, Dawood B, et al. Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects. Blood. 2013;122(25):4090\u20133.","journal-title":"Blood"},{"issue":"1","key":"797_CR309","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/ajmg.a.30090","volume":"129a","author":"PD Grossfeld","year":"2004","unstructured":"Grossfeld PD, Mattina T, Lai Z, Favier R, Jones KL, Cotter F, et al. The 11q terminal deletion disorder: a prospective study of 110 cases. Am J Med Genet A. 2004;129a(1):51\u201361.","journal-title":"Am J Med Genet A"},{"issue":"19","key":"797_CR310","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1002\/ajmg.a.32490","volume":"146a","author":"J Bernaciak","year":"2008","unstructured":"Bernaciak J, Szcza\u0142uba K, Derwi\u0144ska K, Wi\u015bniowiecka-Kowalnik B, Bocian E, Sasiadek MM, et al. Clinical and molecular-cytogenetic evaluation of a family with partial Jacobsen syndrome without thrombocytopenia caused by an approximately 5\u00a0Mb deletion del(11)(q24.3). Am J Med Genet A. 2008;146a(19):2449\u201354.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"797_CR311","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018695","volume":"99","author":"S Chen","year":"2020","unstructured":"Chen S, Wang R, Zhang X, Li L, Jiang Y, Liu R, et al. Ultrasonographic findings and prenatal diagnosis of Jacobsen syndrome: a case report and review of the literature. Medicine. 2020;99(1):e18695.","journal-title":"Medicine"},{"issue":"12","key":"797_CR312","doi-asserted-by":"publisher","first-page":"SS215","DOI":"10.29271\/jcpsp.2022.Supp.S215","volume":"32","author":"S Zhong","year":"2022","unstructured":"Zhong S, Deng Y, Xue L, Li R. Prenatal identification and confirmation of Jacobsen syndrome: A series of four cases. J Coll Physicians Surgeons\u2013Pakistan: JCPSP. 2022;32(12):SS215\u20138.","journal-title":"J Coll Physicians Surgeons\u2013Pakistan: JCPSP"},{"key":"797_CR313","first-page":"CMPed","volume":"8","author":"FJ Sheth","year":"2014","unstructured":"Sheth FJ, Datar C, Andrieux J, Pandit A, Nayak D, Rahman M, et al. Distal deletion of chromosome 11q encompassing Jacobsen syndrome without platelet abnormality. Clin Med Insights: Pediatr. 2014;8:CMPed.","journal-title":"Clin Med Insights: Pediatr"},{"issue":"2","key":"797_CR314","first-page":"203","volume":"55","author":"B Nalbanto\u011flu","year":"2013","unstructured":"Nalbanto\u011flu B, Donma MM, Ni\u015fli K, Paket\u00e7i C, Karasu E, Ozdilek B, et al. Jacobsen syndrome without thrombocytopenia: a case report and review of the literature. Turk J Pediatr. 2013;55(2):203\u20136.","journal-title":"Turk J Pediatr"},{"issue":"1","key":"797_CR315","first-page":"80","volume":"56","author":"P\u00d6 \u015eim\u015fek-Kiper","year":"2014","unstructured":"\u015eim\u015fek-Kiper P\u00d6, Bayram Y, \u00dctine GE, Alanay Y, Boduro\u011flu K. A de novo 11q23 deletion in a patient presenting with severe ophthalmologic findings, psychomotor retardation and facial dysmorphism. Turk J Pediatr. 2014;56(1):80\u20134.","journal-title":"Turk J Pediatr"},{"issue":"5","key":"797_CR316","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000442477","volume":"6","author":"EP Linares Ch\u00e1vez","year":"2016","unstructured":"Linares Ch\u00e1vez EP, Toral L\u00f3pez J, Vald\u00e9s Miranda JM, Gonz\u00e1lez Huerta LM, Perez Cabrera A, del Refugio Rivera Vega M, et al. Jacobsen syndrome: surgical complications due to unsuspected diagnosis, the importance of molecular studies in patients with craniosynostosis. Mol Syndromol. 2016;6(5):229\u201335.","journal-title":"Mol Syndromol"},{"issue":"1","key":"797_CR317","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000452681","volume":"8","author":"A Galv\u00e3o Gomes","year":"2017","unstructured":"Galv\u00e3o Gomes A, Paiva Grangeiro CH, Silva LR, Oliveira-Gennaro FG, Pereira CS, Joaquim TM, et al. Complex mosaic ring chromosome 11 associated with hemizygous loss of 8.6 mb of 11q24. 2qter in atypical Jacobsen syndrome. Mol Syndromol. 2017;8(1):45\u20139.","journal-title":"Mol Syndromol"},{"issue":"4","key":"797_CR318","first-page":"1531","volume":"58","author":"AD Jurc\u0103","year":"2017","unstructured":"Jurc\u0103 AD, Kozma K, Ioana M, Strea\u0163\u0103 I, Petche\u015fi CD, Bembea M, et al. Morphological and genetic abnormalities in a Jacobsen syndrome. Rom J Morphol Embryol. 2017;58(4):1531\u20134.","journal-title":"Rom J Morphol Embryol"},{"issue":"2","key":"797_CR319","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s12041-022-01380-z","volume":"101","author":"J Wang","year":"2022","unstructured":"Wang J, Zhao T, Tan Z, Gong X, Ahemaiti Y, Wei L, et al. Deletion of 11q24. 2-qter in a male child with cleft lip and palate: an atypical feature of Jacobsen syndrome. J Genet. 2022;101(2):37.","journal-title":"J Genet"},{"issue":"3","key":"797_CR320","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1159\/000519149","volume":"13","author":"S Yalcintepe","year":"2022","unstructured":"Yalcintepe S, Zhuri D, Sezginer Guler H, Atli E, Demir S, Atli EI, et al. First report of Jacobsen syndrome with dextrocardia diagnosed with del (11)(q24q25). Mol Syndromol. 2022;13(3):235\u20139.","journal-title":"Mol Syndromol"},{"key":"797_CR321","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-4-9","volume":"4","author":"T Mattina","year":"2009","unstructured":"Mattina T, Perrotta CS, Grossfeld P. Jacobsen syndrome. Orphanet J Rare Dis. 2009;4:9.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"797_CR322","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1177\/2150135118822678","volume":"12","author":"NL Herrick","year":"2021","unstructured":"Herrick NL, Lamberti J, Grossfeld P, Murthy R. Successful management of a patient with Jacobsen syndrome and hypoplastic left heart syndrome. World J Pediatr Congenit Heart Surg. 2021;12(3):421\u20134.","journal-title":"World J Pediatr Congenit Heart Surg"},{"issue":"2","key":"797_CR323","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1586\/ehm.11.5","volume":"4","author":"CPM Hayward","year":"2011","unstructured":"Hayward CPM, Rivard GE. Quebec platelet disorder. Expert Rev Hematol. 2011;4(2):137\u201341.","journal-title":"Expert Rev Hematol"},{"issue":"6","key":"797_CR324","doi-asserted-by":"publisher","first-page":"e274","DOI":"10.1111\/ijlh.13311","volume":"42","author":"CPM Hayward","year":"2020","unstructured":"Hayward CPM, Tasneem S, Rivard GE. Improved platelet counts during prolonged tranexamic therapy for Quebec platelet disorder implicate the underlying fibrinolytic defect as the cause of lower platelet counts. Int J Lab Hematol. 2020;42(6):e274-6.","journal-title":"Int J Lab Hematol"},{"issue":"6","key":"797_CR325","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1182\/blood-2009-07-233965","volume":"115","author":"AD Paterson","year":"2010","unstructured":"Paterson AD, Rommens JM, Bharaj B, Blavignac J, Wong I, Diamandis M. Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator gene. Blood. 2010;115(6):1264\u20136.","journal-title":"Blood"},{"issue":"2","key":"797_CR326","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/MBC.0b013e3282f41e3e","volume":"19","author":"M Diamandis","year":"2008","unstructured":"Diamandis M, Veljkovic DK, Maurer-Spurej E, Rivard GE, Hayward CP. Quebec platelet disorder: features, pathogenesis and treatment. Blood Coagul Fibrinolysis. 2008;19(2):109\u201319.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"797_CR327","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1182\/blood-2003-11-4077","volume":"104","author":"H McKay","year":"2004","unstructured":"McKay H, Derome F, Haq MA, Whittaker S, Arnold E, Adam F, et al. Bleeding risks associated with inheritance of the Quebec platelet disorder. Blood. 2004;104(1):159\u201365.","journal-title":"Blood"},{"issue":"3","key":"797_CR328","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173991","volume":"12","author":"CP Hayward","year":"2017","unstructured":"Hayward CP, Liang M, Tasneem S, Soomro A, Waye JS, Paterson AD, et al. The duplication mutation of Quebec platelet disorder dysregulates PLAU, but not C10orf55, selectively increasing production of normal PLAU transcripts by megakaryocytes but not granulocytes. PLoS ONE. 2017;12(3):e0173991.","journal-title":"PLoS ONE"},{"issue":"2","key":"797_CR329","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1111\/ijlh.12781","volume":"40","author":"CPM Hayward","year":"2018","unstructured":"Hayward CPM, Tasneem S, Rivard GE. Thrombopoietin levels in Quebec platelet disorder-implications for the mechanism of thrombocytopenia. Int J Lab Hematol. 2018;40(2):e33-4.","journal-title":"Int J Lab Hematol"},{"issue":"4","key":"797_CR330","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1160\/TH11-10-0740","volume":"107","author":"CP Hayward","year":"2012","unstructured":"Hayward CP, Moffat KA, Castilloux JF, Liu Y, Seecharan J, Tasneem S, et al. Simultaneous measurement of adenosine triphosphate release and aggregation potentiates human platelet aggregation responses for some subjects, including persons with Quebec platelet disorder. Thromb Haemost. 2012;107(4):726\u201334.","journal-title":"Thromb Haemost"},{"issue":"4","key":"797_CR331","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1182\/blood.V89.4.1121","volume":"89","author":"RF Zwaal","year":"1997","unstructured":"Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood. 1997;89(4):1121\u201332.","journal-title":"Blood"},{"key":"797_CR332","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100733","volume":"46","author":"Y Sang","year":"2021","unstructured":"Sang Y, Roest M, de Laat B, de Groot PG, Huskens D. Interplay between platelets and coagulation. Blood Rev. 2021;46:100733.","journal-title":"Blood Rev"},{"issue":"20","key":"797_CR333","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1182\/blood-2017-05-787259","volume":"130","author":"EO Agbani","year":"2017","unstructured":"Agbani EO, Poole AW. Procoagulant platelets: generation, function, and therapeutic targeting in thrombosis. Blood. 2017;130(20):2171\u20139.","journal-title":"Blood"},{"issue":"Suppl 1","key":"797_CR334","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/ijlh.13866","volume":"44","author":"A Bourguignon","year":"2022","unstructured":"Bourguignon A, Tasneem S, Hayward CPM. Update on platelet procoagulant mechanisms in health and in bleeding disorders. Int J Lab Hematol. 2022;44(Suppl 1):89\u2013100.","journal-title":"Int J Lab Hematol"},{"issue":"1","key":"797_CR335","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-023-00504-6","volume":"11","author":"SE Ahmadi","year":"2023","unstructured":"Ahmadi SE, Shabannezhad A, Kahrizi A, Akbar A, Safdari SM, Hoseinnezhad T, et al. Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer. Biomark Res. 2023;11(1):60.","journal-title":"Biomark Res"},{"issue":"10","key":"797_CR336","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1111\/j.1538-7836.2011.04478.x","volume":"9","author":"T Lhermusier","year":"2011","unstructured":"Lhermusier T, Chap H, Payrastre B. Platelet membrane phospholipid asymmetry: from the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndrome. J Thromb Haemost. 2011;9(10):1883\u201391.","journal-title":"J Thromb Haemost"},{"issue":"3","key":"797_CR337","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00424-016-1790-0","volume":"468","author":"U Oh","year":"2016","unstructured":"Oh U, Jung J. Cellular functions of TMEM16\/anoctamin. Pflugers Arch. 2016;468(3):443\u201353.","journal-title":"Pflugers Arch"},{"issue":"2","key":"797_CR338","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/0002-9343(79)90392-9","volume":"67","author":"HJ Weiss","year":"1979","unstructured":"Weiss HJ, Vicic WJ, Lages BA, Rogers J. Isolated deficiency of platelet procoagulant activity. Am J Med. 1979;67(2):206\u201313.","journal-title":"Am J Med"},{"issue":"7","key":"797_CR339","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1080\/09537104.2019.1693039","volume":"31","author":"SL Millington-Burgess","year":"2020","unstructured":"Millington-Burgess SL, Harper MT. Gene of the issue: ANO6 and Scott syndrome. Platelets. 2020;31(7):964\u20137.","journal-title":"Platelets"},{"issue":"4","key":"797_CR340","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1055\/s-0037-1613576","volume":"89","author":"IC Munnix","year":"2003","unstructured":"Munnix IC, Harmsma M, Giddings JC, Collins PW, Feijge MA, Comfurius P, et al. Store-mediated calcium entry in the regulation of phosphatidylserine exposure in blood cells from Scott patients. Thromb Haemost. 2003;89(4):687\u201395.","journal-title":"Thromb Haemost"},{"issue":"5","key":"797_CR341","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/bjh.14439","volume":"180","author":"P Boisseau","year":"2018","unstructured":"Boisseau P, Bene MC, Besnard T, Pachchek S, Giraud M, Talarmain P, et al. A new mutation of ANO6 in two familial cases of Scott syndrome. Br J Haematol. 2018;180(5):750\u20132.","journal-title":"Br J Haematol"},{"issue":"6","key":"797_CR342","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/j.1365-2141.2009.07935.x","volume":"149","author":"CL Percy","year":"2010","unstructured":"Percy CL, Macartney N, Pollard B, Rayment R, Collins PW. Laboratory monitoring of Scott syndrome. Br J Haematol. 2010;149(6):803.","journal-title":"Br J Haematol"},{"key":"797_CR343","first-page":"161","volume":"26","author":"SG Obaji","year":"2020","unstructured":"Obaji SG, Slatter DA, Tyrrell VJ, Jenkins PV, O\u2019Donnell VB, Collins PW. Uncharacterised bleeding disorders are associated with reduced platelet and microparticle thrombin generation and decreased procoagulant oxidised phosphatidylcholine. Haemophilia. 2020;26:161.","journal-title":"Haemophilia"},{"issue":"1","key":"797_CR344","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/nyas.12049","volume":"1285","author":"MJ Massaad","year":"2013","unstructured":"Massaad MJ, Ramesh N, Geha RS. Wiskott-Aldrich syndrome: a comprehensive review. Ann N Y Acad Sci. 2013;1285(1):26\u201343.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"797_CR345","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/imr.12112","volume":"256","author":"O Matalon","year":"2013","unstructured":"Matalon O, Reicher B, Barda-Saad M. W iskott\u2013A ldrich syndrome protein\u2013dynamic regulation of actin homeostasis: from activation through function and signal termination in T lymphocytes. Immunol Rev. 2013;256(1):10\u201329.","journal-title":"Immunol Rev"},{"issue":"2","key":"797_CR346","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1160\/TH07-09-0568","volume":"99","author":"P Nurden","year":"2008","unstructured":"Nurden P, Nurden AT. Congenital disorders associated with platelet dysfunctions. Thromb Haemost. 2008;99(2):253\u201363.","journal-title":"Thromb Haemost"},{"issue":"13","key":"797_CR347","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1182\/blood-2003-05-1592","volume":"104","author":"Y Jin","year":"2004","unstructured":"Jin Y, Mazza C, Christie JR, Giliani S, Fiorini M, Mella P, et al. Mutations of the Wiskott-Aldrich syndrome protein (WASP): hotspots, effect on transcription, and translation and phenotype\/genotype correlation. Blood. 2004;104(13):4010\u20139.","journal-title":"Blood"},{"key":"797_CR348","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s004390050162","volume":"98","author":"D Schindelhauer","year":"1996","unstructured":"Schindelhauer D, Weiss M, Hellebrand H, Golla A, Hergersberg M, Seger R, et al. Wiskott-aldrich syndrome: no strict genotype-phenotype correlations but clustering of missense mutations in the amino-terminal part of the WASP gene product. Hum Genet. 1996;98:68\u201376.","journal-title":"Hum Genet"},{"issue":"1","key":"797_CR349","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10875-017-0453-z","volume":"38","author":"F Candotti","year":"2018","unstructured":"Candotti F. Clinical manifestations and pathophysiological mechanisms of the Wiskott-Aldrich syndrome. J Clin Immunol. 2018;38(1):13\u201327.","journal-title":"J Clin Immunol"},{"issue":"3","key":"797_CR350","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nri2724","volume":"10","author":"AJ Thrasher","year":"2010","unstructured":"Thrasher AJ, Burns SO. WASP: a key immunological multitasker. Nat Rev Immunol. 2010;10(3):182\u201392.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"797_CR351","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1182\/blood.V55.2.243.243","volume":"55","author":"H Ochs","year":"1980","unstructured":"Ochs H, Slichter S, Harker L, Von Behrens W, Clark R, Wedgwood R. The wiskott-aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood. 1980;55(2):243\u201352.","journal-title":"Blood"},{"key":"797_CR352","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/ijlh.12814","volume":"40","author":"P Gresele","year":"2018","unstructured":"Gresele P, Falcinelli E, Bury L. Laboratory diagnosis of clinically relevant platelet function disorders. Int J Lab Hematol. 2018;40:34\u201345.","journal-title":"Int J Lab Hematol"},{"issue":"1","key":"797_CR353","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jaci.2018.04.017","volume":"142","author":"SC Chiang","year":"2018","unstructured":"Chiang SC, Vergamini SM, Husami A, Neumeier L, Quinn K, Ellerhorst T, et al. Screening for Wiskott-Aldrich syndrome by flow cytometry. J Allergy Clin Immunol. 2018;142(1):333\u20135. e8.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"797_CR354","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/0888-7543(89)90315-7","volume":"4","author":"WL Greer","year":"1989","unstructured":"Greer WL, Kwong PC, Peacocke M, Ip P, Rubin LA, Siminovitch KA. X-chromosome inactivation in the Wiskott-Aldrich syndrome: a marker for detection of the carrier state and identfication of cell lineages expressing the gene defect. Genomics. 1989;4(1):60\u20137.","journal-title":"Genomics"},{"key":"797_CR355","doi-asserted-by":"crossref","unstructured":"Peacocke M, Siminovitch KA. Linkage of the Wiskott-Aldrich syndrome with polymorphic DNA sequences from the human X chromosome. Proceedings of the National Academy of Sciences. 1987;84(10):3430-3.","DOI":"10.1073\/pnas.84.10.3430"},{"issue":"8","key":"797_CR356","doi-asserted-by":"publisher","DOI":"10.3390\/genes14081519","volume":"14","author":"A Mitrakos","year":"2023","unstructured":"Mitrakos A, Kosma K, Makrythanasis P, Tzetis M. Prenatal chromosomal microarray analysis: does increased resolution equal increased yield? Genes. 2023;14(8):1519.","journal-title":"Genes"},{"issue":"8","key":"797_CR357","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23896","volume":"35","author":"L Zhang","year":"2021","unstructured":"Zhang L, Yu J, Xian Y, Wen X, Guan X, Guo Y, et al. Application of high-throughput sequencing for hereditary thrombocytopenia in southwestern China. J Clin Lab Anal. 2021;35(8):e23896.","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"797_CR358","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/09537104.2016.1246715","volume":"28","author":"JM Bastida","year":"2017","unstructured":"Bastida JM, Del Rey M, Revilla N, Benito R, Perez-Andr\u00e9s M, Gonz\u00e1lez B, et al. Wiskott-aldrich syndrome in a child presenting with macrothrombocytopenia. Platelets. 2017;28(4):417\u201320.","journal-title":"Platelets"},{"issue":"18","key":"797_CR359","doi-asserted-by":"publisher","first-page":"5279","DOI":"10.1182\/bloodadvances.2021006789","volume":"6","author":"D Marx","year":"2022","unstructured":"Marx D, Dupuis A, Eckly A, Molitor A, Olagne J, Touchard G, et al. A gain-of-function variant in the Wiskott-Aldrich syndrome gene is associated with a MYH9-related disease-like syndrome. Blood Adv. 2022;6(18):5279\u201384.","journal-title":"Blood Adv"},{"key":"797_CR360","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.627651","volume":"12","author":"D Suri","year":"2021","unstructured":"Suri D, Rikhi R, Jindal AK, Rawat A, Sudhakar M, Vignesh P, et al. Wiskott Aldrich syndrome: a multi-institutional experience from India. Front Immunol. 2021;12:627651.","journal-title":"Front Immunol"},{"issue":"1","key":"797_CR361","doi-asserted-by":"publisher","DOI":"10.1111\/sji.13115","volume":"95","author":"J Jiang","year":"2022","unstructured":"Jiang J, Zhou J, Wei M, Singh S, Nikuze L, Huang L, et al. Clinical and molecular characteristics of Wiskott-Aldrich syndrome in five unrelated Chinese families. Scand J Immunol. 2022;95(1):e13115.","journal-title":"Scand J Immunol"},{"issue":"1","key":"797_CR362","doi-asserted-by":"publisher","first-page":"69","DOI":"10.5582\/irdr.2023.01102","volume":"13","author":"Y Sun","year":"2024","unstructured":"Sun Y, Song X, Pan H, Li X, Sun L, Song L, et al. Wiskott-aldrich syndrome: a new synonym mutation in the WAS gene. Intractable Rare Dis Res. 2024;13(1):69\u201372.","journal-title":"Intractable Rare Dis Res"},{"issue":"4","key":"797_CR363","first-page":"345","volume":"11","author":"S Safaei","year":"2012","unstructured":"Safaei S, Fazlollahi MR, Houshmand M, Hamidieh AA, Bemanian MH, Alavi S, et al. Detection of six novel mutations in WASP gene in fifteen Iranian Wiskott-Aldrich patients. Iran J Allergy Asthma Immunol. 2012;11(4):345\u20138.","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"5","key":"797_CR364","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.aller.2015.11.002","volume":"44","author":"M Eghbali","year":"2016","unstructured":"Eghbali M, Sadeghi-Shabestari M, Najmi Varzaneh F, Zare Bidoki A, Rezaei N. Novel WASP mutation in a patient with Wiskott-Aldrich syndrome: case report and review of the literature. Allergol Immunopathol (Madr). 2016;44(5):450\u20134.","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"3","key":"797_CR365","first-page":"253","volume":"11","author":"M Fathi","year":"2019","unstructured":"Fathi M, Shahraki H, Sharif Rahmani E, Rahimi H, Omidi P, Darvishi S, et al. Whole exome sequencing of an X-linked thrombocytopenia patient with normal sized platelets. Avicenna J Med Biotechnol. 2019;11(3):253\u20138.","journal-title":"Avicenna J Med Biotechnol"},{"key":"797_CR366","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2147\/JBM.S232650","volume":"12","author":"KK Mallhi","year":"2021","unstructured":"Mallhi KK, Petrovic A, Ochs HD. Hematopoietic stem cell therapy for Wiskott-Aldrich syndrome: improved outcome and quality of life. J Blood Med. 2021;12:435\u201347.","journal-title":"J Blood Med"},{"key":"797_CR367","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26692","author":"M Gabelli","year":"2017","unstructured":"Gabelli M, Marzollo A, Notarangelo LD, Basso G, Putti MC. Eltrombopag use in a patient with Wiskott-Aldrich syndrome. Pediatr Blood Cancer. 2017. https:\/\/doi.org\/10.1002\/pbc.26692.","journal-title":"Pediatr Blood Cancer"},{"key":"797_CR368","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.883446","volume":"13","author":"K-W Chan","year":"2022","unstructured":"Chan K-W, Wong C-Y, Leung D, Yang X, Fok SF, Mak PH, et al. Targeted gene Sanger sequencing should remain the first-tier genetic test for children suspected to have the five common X-linked inborn errors of immunity. Front Immunol. 2022;13:883446.","journal-title":"Front Immunol"},{"issue":"1","key":"797_CR369","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17626-2","volume":"11","author":"R Rai","year":"2020","unstructured":"Rai R, Romito M, Rivers E, Turchiano G, Blattner G, Vetharoy W, et al. Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott-Aldrich syndrome. Nat Commun. 2020;11(1):4034.","journal-title":"Nat Commun"},{"key":"797_CR370","first-page":"841","volume-title":"Confirmatory testing for diagnosis of platelet disorders","author":"R He","year":"2019","unstructured":"He R, Chen D. Confirmatory testing for diagnosis of platelet disorders. Transfusion Medicine and Hemostasis: Elsevier; 2019. pp. 841\u20138."},{"issue":"1","key":"797_CR371","first-page":"1","volume":"63","author":"A Dorgalaleh","year":"2017","unstructured":"Dorgalaleh A, Tabibian S, Shamsizadeh M. Inherited platelet function disorders (IPFDs). Clin Lab. 2017;63(1):1\u201313.","journal-title":"Clin Lab"},{"issue":"2","key":"797_CR372","first-page":"e55064","volume":"16","author":"E Arslan Davulcu","year":"2024","unstructured":"Arslan Davulcu E, Karaca E, Akad Soyer N. A case of myosin heavy chain 9-Related disorder following splenectomy due to misdiagnosis of idiopathic thrombocytopenic purpura. Cureus. 2024;16(2):e55064.","journal-title":"Cureus"},{"issue":"1","key":"797_CR373","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2023.102305","volume":"8","author":"P Gresele","year":"2024","unstructured":"Gresele P, Falcinelli E, Bury L, Alessi MC, Guglielmini G, Falaise C, et al. Association of laboratory test results with the bleeding history in patients with inherited platelet function disorders (the bleeding assesment tool - laboratory tests substudy): communication from the platelet physiology ISTH-SSC. Res Pract Thromb Haemost. 2024;8(1):102305.","journal-title":"Res Pract Thromb Haemost"},{"issue":"S1","key":"797_CR374","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1002\/pbc.24345","volume":"60","author":"SJ Israels","year":"2013","unstructured":"Israels SJ, Rand ML. What we have learned from inherited platelet disorders. Pediatr Blood Cancer. 2013;60(S1):S2-7.","journal-title":"Pediatr Blood Cancer"},{"key":"797_CR375","doi-asserted-by":"crossref","unstructured":"Ghasemi, B., Dorgalaleh, A. (2023). Bernard-Soulier Syndrome: Diagnosis and Management. In: Dorgalaleh, A. (eds) Congenital Bleeding Disorders . Springer, Cham.","DOI":"10.1007\/978-3-031-43156-2"},{"issue":"9","key":"797_CR376","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1111\/jth.12650","volume":"12","author":"P Gresele","year":"2014","unstructured":"Gresele P, Harrison P, Bury L, Falcinelli E, Gachet C, Hayward C, et al. Diagnosis of suspected inherited platelet function disorders: results of a worldwide survey. J Thromb Haemost. 2014;12(9):1562\u20139.","journal-title":"J Thromb Haemost"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-025-00797-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-025-00797-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-025-00797-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T14:02:18Z","timestamp":1765375338000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12959-025-00797-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":376,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["797"],"URL":"https:\/\/doi.org\/10.1186\/s12959-025-00797-7","relation":{},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"30 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"119"}}